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Mycobacterial pathogens are responsible for an ongoing public health crisis.
Mycobacterium abscessus is the causative agent of lung infections that disproportionately
affect immunocompromised individuals and is the most intrinsically antibiotic-resistant
bacterial species known. These characteristics make M. abscessus infections difficult to treat,
with a success rate of only 45%. While some extensively resistant isolates are caused by
mutations in drug targets, others appear to be a result of increased intrinsic drug resistance.
Common among these strains is the presence of integrated viral genomes (prophage) that are
known to contribute to fitness and antibiotic resistance in other pathogens but whose roles are
largely unknown in mycobacteria.
M. chelonae is an opprtunisitc pathogen that is closely related to M. abscessus. We have
demonstrated that the presence of an M. abscessus cluster R prophage, McProf, in M.
chelonae, increased resistance to antibiotics, such as amikacin, relative to strains lacking the

prophage. The presence of McProf also enhances amikacin resistance in response to sub-lethal
concentrations of antibiotics, or other cellular stresses such as infection by a second phage,
BPs. Relative to strains carrying only one of the prophages or no prophage, the strain carrying
two prophages, BPs and McProf, had the highest amikacin resistance. This strain also showed
increased expression of the transcriptional activator, whiB7, which promotes expression of
intrinsic antibiotic resistance genes. We investigated the role of BPs lysogenic gene products in
the presence of McProf and showed that individual expression of these genes does not
contribute to whiB7 upregulation, indicating that McProf likely plays a larger role in mediating
this intrinsic resistance. We identified a McProf-encoded polymorphic toxin system and
evaluated its effect on whiB7 expression in M. chelonae carrying the BPs prophage. The
polymorphic toxin system elevates whiB7 expression but does not fully account for the
dramatic increase in expression observed in the M. chelonae strain carrying both prophages.
This work suggests that prophages play a role in increasing intrinsic antibiotic resistance
and stress adaptation in pathogenic mycobacteria. Given that most pathogenic mycobacteria
carry one or more prophages, characterizing how prophages regulate antibiotic resistance genes
and adaptation to stresses will provide insight for developing more effective therapies for
mycobacterial diseases.
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CHAPTER 1
REVIEW OF THE LITERATURE
1.1 Mycobacteria are a major public health threat
Mycobacteria are Gram-positive, non-motile, non-spore forming bacilli (Percival et al.,
2014). These species are characterized by their thick cell walls, including an outer layer studded
with mycolic acid (Alderwick et al., 2015). Mycobacteria are ubiquitous in air, soil, and water
(Percival et al., 2014). More than 170 species have been identified thus far, and can be
characterized as obligate, opportunistic, or non-pathogens (Fedrizzi et al., 2017). Genetically,
mycobacteria can be distinguished by 16S rRNA sequence homology and high GC content, as
well as presence of mycolic acid biosynthesis markers (Fedrizzi et al., 2017).
Mycobacteria are further grouped based on growth rate. The slow growth group requires
more than 7 days to form colonies on solid media, while the rapid growth group forms colonies
in 2 – 5 days (Bachmann et al, 2020). Slow-growing mycobacteria include obligate intracellular
pathogens, such as M. tuberculosis, M. bovis, and M. leprae. Fast-growing species include both
opportunistic pathogens and non-pathogens and are ubiquitous in the environment. Examples
include pathogenic species, M. abscessus and M. chelonae, and non-pathogens, M. smegmatis
and M. gilvum (Bachmann et al., 2020; Prasanna et al., 2013). Mycobacteria are also commonly
characterized as belonging to the Mycobacterium tuberculosis complex (MTBC) or as nontuberculous mycobacteria (NTM). The MTBC consists of all strains capable of causing
tuberculosis in humans (Fan et al. 2015). Tuberculosis continues to press a major economic and
public health burden upon the globe (WHO, 2020).
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Prior to the COVID-19 pandemic, tuberculosis (TB), caused by Mycobacterium tuberculosis,
was the leading cause of death by an infectious agent and still ranks in the top ten causes of
death worldwide (WHO, 2020). Responsible for 2 billion current infections, 10 million new
infections, and 1.4 million deaths in 2019, M. tuberculosis continues to thrive as a global health
threat (WHO, 2020). Immunocompromised individuals, including those with human
immunodeficiency virus (HIV), are especially susceptible to contracting TB, which is the leading
cause of death among HIV-positive patients (WHO, 2020). TB is primarily a pulmonary disease,
although disseminated infection is possible and is lethal in 50% of cases without
chemotherapeutic intervention (Pai et al., 2016). M. tuberculosis is contracted through airborne
transmission of respiratory droplets. Once inside the body, M. tuberculosis infects alveolar
macrophage in the lungs. A collection of immune cells moves to encase the bacteria, resulting
in granuloma formation. When bacterial cells are contained within granulomas, infection
remains asymptomatic. However, the ability of M. tuberculosis to survive in macrophage leads
to a persistent infection known as latent tuberculosis infection, or LTBI (Pai et al., 2016). If the
bacterial load becomes too great for a granuloma to contain, cells will escape and can
disseminate throughout the body and/or be expelled by the lungs. At this point, the patient has
an active TB infection which is both symptomatic and contagious (Pai et al., 2016). Symptoms
of active infection include fever, fatigue, weight loss, cough, and in some cases, hemoptysis.
These symptoms range in severity from mild to deadly (Pai, 2016). In addition to the health
crisis caused by M. tuberculosis, incidence of disease caused by fast-growing opportunistic
mycobacterial pathogens, especially M. abscessus, has been increasing (Bachmann et al., 2020;
Johansen et al., 2020).
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While not as prominent as M. tuberculosis, prevalence of NTM infections, especially M.
abscessus infections, are on the rise, with a steep increase in the last decade (Johansen et al.,
2020). This increase can be attributed to environmental presence of NTM, as well as growing
prevalence of risk factors, such as old age, immunosuppression, and chronic lung conditions,
including cystic fibrosis. In fact, 10 – 20% of cystic fibrosis patients will develop M. abscessus
infections (Johansen et al., 2020). While chance of infection is heightened in those with
predispositions, NTM are capable of causing disease in otherwise healthy individuals as well
(Johansen et al., 2020). Similar to TB, M. abscessus infection also results in granuloma
formation, allowing the infection to persist for as long as several decades (Johansen et al.,
2020). In severe cases, M. abscessus may cross the blood-brain barrier and cause cerebral
abscesses and meningitis (Hurst-Hess et al., 2017). Due to extensive antibiotic resistance, the
incidence rate of M. abscessus infection is greater than that of M. tuberculosis in most
developed countries, with a successful treatment rate of only 45% (Griffith, 2019; Johansen et
al., 2020).
1.2 Emergence of multidrug resistance in pathogenic mycobacteria
Pathogenic mycobacteria are well known for intrinsic mechanisms of drug resistance that
make effective treatment of infections difficult. In fact, M. abscessus is one of the most
intrinsically resistant species known. While M. tuberculosis and M. abscessus share many
features of intrinsic resistance, even frontline TB drugs are ineffective against this organism
(Nessar et al., 2012). For this reason, the known mechanisms of drug resistance in M. abscessus
will be covered in this review.
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Intrinsic resistance refers to naturally occurring characteristics that organisms possess to
nullify the impact of antibiotics. The first line of defense in mycobacteria is the cell envelope. It
is characterized as thick and waxy, with 60% lipid content. The structure of this envelope results
in low permeability, making it difficult for antibiotics and other extracellular compounds to
enter the cell (Nessar et al., 2012). Notably, mycobacteria have fewer porins spanning the cell
envelope than observed in Gram-negative bacteria, further limiting antibiotic uptake (van Ingen
et al., 2012). The membrane also works cooperatively with intracellular signals to shuttle
unwanted compounds out of the cell (Nessar et al., 2012). M. abscessus encodes numerous
proteins that function to either modify antibiotics or alter the drug target itself to render the
drugs inactive. Rifampicin resistance is conferred by an ADP-ribosyltransferase, arr, which
modifies the drug by catalyzing the addition of an ADP-ribose group (Rominski et al., 2017).
Acetylases and phosphotransferases, as well as the tap efflux pump are responsible for
aminoglycoside resistance (Nessar et al., 2012; van Ingen et al., 2012). -lactamases degrade lactam antibiotics (Nessar et al. 2012). Several efflux pumps, including tap and tetV result in
tetracycline resistance (van Ingen et al., 2012). Quinolone resistance is conferred through
acetylases and efflux pumps, including lfrA (van Ingen et al., 2012). The erm methylase
methylates 23S rRNA to prevent macrolide binding (Nash et al., 2009). The extent of intrinsic
drug resistance in mycobacteria leaves few effective treatment options.
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Figure 1.1 Intrinsic mechanisms of antibiotic resistance in pathogenic mycobacteria. This
schematic represents many mechanisms of intrinsic resistance displayed by M. abscessus,
including drug efflux pumps and drug-modifying enzymes. Many of the genes responsible
for antibiotic resistance are positively regulated by whiB7.

Standard treatment for active TB infection includes a four-drug regimen consisting of
isoniazid, rifampicin, pyrazinamide, and ethambutol for a minimum of six months (Pai et al.,
2016; WHO, 2020). Treatment for M. abscessus infection involves a combination therapy of
clarithromycin and amikacin, along with an injectable antimicrobial, such as cefoxitin.
Treatment is long in duration, often 12 or more months, and can result in toxic side effects
typical of amikacin treatment (Hurst-Hess et al., 2017). In severe cases, surgical intervention to
remove infected tissue may be attempted (van Ingen et al., 2012). Treatment for both M.
tuberculosis and M. abscessus infections has been further limited by emergence of multi-drug
resistant (MDR) and extensively resistant (XDR) strains.
5

The definition and prevalence of MDR and XDR TB infections has been well characterized.
MDR strains are resistant to both rifampicin and isoniazid. XDR strains are resistant to
fluoroquinolones and at least one injectable aminoglycoside in addition to rifampicin and
isoniazid (Pai et al., 2016). The WHO estimates that 3.3% of new cases and 18% of existing cases
are MDR, with a 10% increase in treatment of MDR strains since 2017 (WHO, 2020).
Additionally, 12,350 people developed XDR infections in 2019 (WHO, 2020). All acquired
antibiotic resistance observed in M. tuberculosis thus far are a result of spontaneous point
mutations within drug targets (Nasiri et al., 2017). Resistance to isoniazid, rifampicin,
pyrazinamide, and ethambutol are caused by mutations in katG, rpoB, pncA, and embCAB
respectively (Nasiri et al., 2017).
The prevalence of M. abscessus infections is not as well quantified and are often
misidentified. However, the incidence of new M. abscessus infections has been on the rise over
the last decade (Johansen et al., 2020). While M. abscessus is already intrinsically resistant to
most drug groups, strains have also acquired additional resistance to aminoglycosides,
macrolides, or both. In fact, some strains have developed resistance to all known antibiotics
(Johansen et al., 2020). Spontaneous point mutations in rrs, which encodes 16S rRNA, are
associated with aminoglycoside resistance (Nessar et al., 2012; Guo et al., 2020; Johansen et al.,
2020). To date, four possible point mutations have been identified that confer this resistance
(Nessar et al., 2012). Point mutations within the 23S rRNA encoding-gene, rrl, leads to
macrolide resistance (Guo et al., 2020; Johansen et al., 2020). However, not all extensively
resistant phenotypes can be attributed to genetic mutations, suggesting that other unidentified
mechanisms may play a role in antibiotic resistance (Nessar et al., 2012). Common among all
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MDR strains is the upregulation of transcriptional activator, whiB7, which regulates genes that
confer intrinsic antibiotic resistance (Guo et al., 2020).
1.3 Transcriptional activator, whiB7, mediates antibiotic resistance
The whiB family (whiB1 – 7) of genes are a group of transcriptional regulators found in the
Actinomyces genus, which includes significant pathogenic species such as mycobacteria,
streptomyces, and nocardia (Burian et al., 2015; Barka et al., 2016). These transcription factors
are characterized by four conserved cysteine residues and a helix-turn-helix DNA binding motif
(Larsson et al., 2012). Each of the seven genes of the whiB family contributes to virulence, and
the majority have been assigned additional functions (Bush, 2018). whiB1, whiB3, whiB4, and
whiB7 assist in maintaining redox balance. whiB2 plays a role in cell growth and septation.
whiB7 plays an especially pivotal role in virulence by regulating genes involved in antibiotic
resistance and survival in macrophage (Morris et al., 2005; Burian et al., 2015; Bush, 2018).
whiB7 is a transcriptional activator that mediates genes directly involved in antibiotic
resistance, as well as antibiotic-induced stress response genes, including those involved in
redox and metabolism (Morris et al., 2015; Burian et al., 2012). It has a signature structure that
includes four conserved cysteine residues, a G(V/I)WGG turn, and a C-terminal AT-hook
necessary for DNA binding (Burian et al., 2013). Expression of whiB7 occurs from an antibioticinducible promoter and is transcribed by a SigA-containing RNA polymerase (Burian et al.,
2018). In addition, the whiB7 promoter contains an AT-rich motif that allows WhiB7 to bind and
amplify its own expression, making it autoregulatory (Burian et al., 2013). Burian et al. (2015)
identified 86 drugs capable of inducing the whiB7 promoter after screening 600 compounds,
including every available antibiotic and other biological agents. The 86 inducing compounds
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belong to a variety of structural and drug target groups. whiB7 is also upregulated 14-fold in M.
tuberculosis when cells are introduced into murine macrophage (Larsson et al., 2012). It is
predicted that this induction is caused by the reducing agent, glutathione, encountered in
macrophage (Burian et al., 2015).
Interestingly, the whiB7 promoter is constitutively active at a low level in the absence of
antibiotics, however the whiB7 open reading frame (ORF) itself is not transcribed due to the
presence of a Rho-independent terminator upstream of the whiB7 ORF. An upstream ORF
(uORF) located between the whiB7 promoter and terminator is predicted to act, in conjunction
with the terminator, as a riboregulatory attenuation system (Burian et al., 2018). In these
systems, the presence of a regulatory metabolite can affect translation of the uORF, which in
turn alters the secondary structure of the terminator sequence. This results in anti-termination
and subsequent transcription of the downstream gene (Dar et al., 2016). In the case of whiB7,
anti-termination is achieved through exposure to sub-lethal concentrations of antibiotics and
other biologically active compounds (Burian et al., 2018). Once translated, WhiB7 stimulates
expression of other genes within its regulon, including tap, tetV, and eis, by binding to the SigA
subunit of RNA polymerase and directing it to target genes (Burian et al., 2018).
While whiB7 homologs are conserved in mycobacteria, the number and function of genes
within the regulon differs between species. M. tuberculosis encodes 12 genes belonging to the
WhiB7 regulon, only four of which contribute to antibiotic resistance (tap, eis, erm, and tetV)
(Morris et al., 2005; Shur et al., 2017). In contrast, M. abscessus encodes 128 genes belonging
to the whiB7 regulon, including those identified in M. tuberculosis. Several have been identified
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with direct roles in intrinsic antibiotic resistance that are upregulated upon whiB7 induction via
drug exposure (Hurst-Hess et al., 2017).
WhiB7 regulates an erythromycin ribosome methylase (erm) that contributes to resistance
to macrolides, a frontline ribosome-targeting drug family used to treat M. abscessus infections
(Luthra et al., 2018). They cease protein synthesis by targeting the polypeptide exit tunnel and
causing tRNA dissociation (Luthra et al., 2018). The erythromycin ribosome methylase, or erm,
methylates 23S rRNA at the A2058 position to lower macrolide binding affinity (Luthra et al.,
2018). An erm homolog, erm(41), is regulated by whiB7 and confers macrolide resistance in two
of three M. abscessus subspecies (M. massiliense lacks this gene) (Nash et al., 2009).
Efflux pumps are energy-dependent membrane proteins that export compounds out of cells
(Ramon-Garcia et al., 2012). A tetracycline/aminoglycoside efflux pump (tap) is regulated by
whiB7 and, as the name suggests, confers resistance to tetracyclines and aminoglycosides by
shuttling them out of the cell (Ramon-Garcia et al., 2012). Shur et al. (2017) have also provided
evidence that Tap is capable of exporting macrolides and fluoroquinolones. In addition, Tap
plays a role in stationary phase survival, and therefore latency, by shuttling toxic waste
products out of the cell (Ramon-Garcia et al., 2012).
whiB7 controls the expression of several GCNS-related N-acetyltransferase (GNAT) family
genes in M. abscessus (Luthra et al., 2018). This family includes the enhanced intracellular
survival, or eis, gene known for its role in macrophage intracellular survival and kanamycin
resistance in M. tuberculosis (Chen et al., 2012). N-acetyltransferases target aminoglycosides.
Aminoglycosides, like macrolides, inhibit protein synthesis. However, they do so by binding 16S
rRNA, although the binding site differs by drug within this class (Luthra et al., 2018). 2’-N-
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acetyltransferases are conserved in mycobacteria and acetylate aminoglycosides with a 2’
amino group, including gentamycin, tobramycin, and kanamycin (Luthra et al., 2018). The whiB7
regulon of M. abscessus encodes two eis genes. eis1 is a homolog of the eis gene in M.
tuberculosis. eis2 is a homolog of the eis gene in Anabaena variabilis and is significant in that it
confers resistance to amikacin, a frontline drug used to treat M. abscessus infection (Luthra et
al., 2018). In terms of intracellular survival, eis acetylates, and therefore activates, phosphatase
16/mitogen-activated protein kinase phosphatase-7 (DUSP16/MPK-7). DUSP16/MPK-7 inhibits
death of infected macrophage (Luthra et al., 2018).
Many MDR and XDR isolates of M. abscessus demonstrate a >10-fold increase in whiB7
expression, along with an increase in expression of associated antibiotic resistance genes,
relative to drug-susceptible strains (Wu et al., 2019). The cause of this upregulation is not
known; however, it is hypothesized that exposure to sub-inhibitory clarithromycin as a result of
drug concentration gradients encountered in tissues during treatment of M. abscessus infection
results in upregulation of whiB7 (Pryjma et al., 2017). Similarly, reduced drug penetration
observed during treatment of M. tuberculosis infection is associated with acquired drug
resistance, although whether whiB7 expression is impacted has not been measured (Dheda et
al., 2018). There is also evidence that prophage can alter bacterial antibiotic resistance (Wang
et al., 2010). While prophage-encoded virulence genes appear to be more abundant in
mycobacteriophage identified in clinical isolates of pathogenic NTM compared to
environmental mycobacteriophage, their impact on increased antibiotic resistance has not
been explored (Glickman et al., 2020).
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1.4 Bacteriophage are the most abundant biological entity
Bacteriophage (phage) are viruses that infect bacteria (Haq et al., 2011). They are the
most abundant biological entity on Earth, quantified at approximately 1031 particles (Suttle,
2016). The majority of phage belong to the order Caudovirales, or tailed, double-stranded DNA
phage, rather than the Inoviridae, or filamentous phage group (Hatfull and Hendrix 2011;
Knezevic et al., 2021). The structure of these phage particles consists of an icosahedral head
that encapsulates genetic material, as well as a fibrous tail. Tailed phage are categorized into
three different families based on tail structure: myoviridae (contractile tails), siphoviridae (long,
non-contractile tails), and podoviridae (short non-contractile tails), and possess incredibly
diverse genomes (Hatfull and Hendrix 2011). As of January 2021, 18,679 Actinobacteria phages
have been isolated, and 3,698 of these have been fully sequenced and characterized (Russell
and Hatfull, 2017). Of these phages, 11,468 are able to infect mycobacteria. Phage are
categorized by cluster. Phage within the same cluster share at least 35% shared gene content
(Pope et al., 2017; Dedrick et al., 2021). To date, there are 140 clusters and 157 subclusters.
There are 63 phages with no known relatives which belong to the singleton cluster (Russell and
Hatfull, 2017).
Phage replicate by two distinct pathways: the lytic and lysogenic cycle. Phage infection
begins with attachment to the host cell via interactions with a specific host cell receptor,
followed by transfer of genetic material into the bacterial host (Stone et al., 2019). Lytic phage
strictly replicate through the lytic cycle and use host machinery to propagate within the cell,
beginning with replication of genetic material, then expression of particle structural proteins.
These products are used to assemble new viral particles. Once the host cell is filled to capacity
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with viral particles, phage-encoded proteins (holins and lysins) facilitate cell lysis, releasing
progeny into the extracellular environment (Haq et al., 2011). The progeny then moves on to
infect other cells and repeat the process. Temperate phages are capable of carrying out both
the lytic and lysogenic cycle. During lysogeny, the phage genome is inserted into the genome of
the bacterial host via phage- and host-encoded proteins. The bacterium carrying the integrated
phage genome is called a lysogen. Once a phage is integrated into its host, it is termed a
prophage. The prophage genome remains latent, replicating along with the bacteria (Haq et al.,
2011).
Figure
1.2
Phage
replication
cycles.
Phage replicate by
either lytic or lysogenic
growth.

Temperate phage, those able to form lysogens, typically maintain lysogeny through
expression of an immunity repressor gene which serves as a transcriptional regulator to inhibit
expression of phage replication and structural elements typical of lytic growth. Repressors also
confer immunity to infection by related phage. (Petrova et al., 2015). However, a process
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known as induction may occur randomly in a small fraction of cells, or in response to stress in a
large fraction of cells. During this process, concentrations of the immunity repressor decrease
in the cell, allowing expression of lytic genes and the production of virions (Casjens, 2003).
Some temperate phages additionally encode a repressor gene, control of repressor’s operator
(cro), which promotes lytic gene expression and replication by inhibiting expression of the
immunity repressor (Gao et al., 2013). Lytic phages are now being harnessed for their ability to
kill bacterial cells (Dedrick et al., 2019).
Lytic phages, and phages engineered to be lytic, have the potential to revolutionize
medicine by providing an alternative to antibiotic treatment, specifically in regard to bacteria
that have developed multi-drug resistance (Dedrick et al., 2019; Jault et al., 2018; Altamirano et
al., 2019). Phage therapy utilizes the lytic aspect of viruses as means to target and destroy
pathogenic bacteria (Hatfull, 2014). In fact, phage therapy was successfully employed recently
to treat a CF patient with a lethal MDR M. abscessus infection following lung transplantation
(Dedrick et al., 2019). A cocktail of three phages (Muddy, ZoeJ, and BPs) were given both
intravenously and topically twice daily for 32 weeks to treat disseminated and wound
infections. Two of the phages, ZoeJ and BPs, lytically infected M. abscessus at a poor efficiency.
To remediate this, the phages were genetically engineered to remove their respective immunity
repressor genes to force strictly lytic infections (Dedrick et al., 2019). Prior to this treatment
regimen, the patient, only 15 years old, had been placed on palliative care as a result of the
infection. Throughout treatment, the patient improved clinically, skin nodules resolved, and M.
abscessus was no longer detectable in sputum. This is the first example where phage therapy
was employed to successfully treat a mycobacterial infection (Dedrick et al., 2019).
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The results of this study are promising for future treatment of XDR M. abscessus
infections and has paved the way for development of phage therapies aiming to prevent and
treat other mycobacterial infections, especially M. tuberculosis. Carrigy et al. (2019) has
demonstrated that inhalation of nebulized mycobacteriophage, D29, is an effective prophylactic
measure for M. tuberculosis infection in mice, modeling a potential preventative treatment
option for high-risk individuals. Additionally, a five-phage cocktail has been developed to target
the MTBC and was successful in killing M. tuberculosis strains in vitro (Guerro-Bustamante et
al., 2021). While lytic phages may be harnessed to treat bacterial infections, prophage may
enhance infections by increasing fitness and virulence of its host.
1.5 Prophage impact host fitness and virulence
The presence of prophage is extensive in bacterial pathogens and likely play a significant
role in bacterial evolution (Brussow et al., 2004). Up to 20% of bacterial chromosomes consist
of prophage or prophage-like elements (Fan et al., 2014). Interestingly, genes expressed from
prophage may alter the host in a beneficial manner and phage-encoded genes have been
shown to increase virulence, antibiotic resistance, and antibiotic tolerance in lysogen
populations (Casjens, 2003; Kaper et al., 2004; Hyder and Streitfeld, 1978; Muniesa et al., 2013;
Wang et al., 2016).
Prophage-encoded toxins are the most obvious mechanism of increasing pathogenesis
(Wang et al., 2016). For example, Shiga toxin (stx)-encoding prophage are present in bacterial
strains responsible for enterohemorrhagic Escherichia coli (EHEC) infections that result in
bloody diarrhea and other complications (Kaper et al., 2004). The toxin is only expressed during
late lytic infection. However, stress, including antibiotic treatment, triggers induction of stx-
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encoding prophage into lytic replication, therefore resulting in toxin production (Kaper et al,
2004). Similarly, the filamentous phage, Pf4, that resides in Pseudomonas aeruginosa influences
biofilm formation (Webb et al., 2004; Rice et al., 2009). This is not a result of a phage-encoded
toxin but demonstrates a direct role in increasing virulence. The presence of Pf4 makes
treatment of P. aeruginosa infection difficult and is especially detrimental to CF patients who
often harbor persistent infections (Webb et al., 2004; Wang et al., 2016).
Prophages may serve as genetic switches to regulate bacterial gene expression under
different conditions if integration disrupts gene function (Rabinovich et al., 2012). For example,
Listeria monocytogenes, a human pathogen, encodes a competence system necessary for
phagosomal escape and intracellular growth. This system is rendered nonfunctional due to the
presence of prophage, A118, that integrates into the competence system activator, comK
(Rabinovich et al., 2012). A118 serves as a genetic switch by excising from the host genome, but
not entering lytic growth, upon encountering the intracellular environment of macrophage.
Excision results in an intact comK, leading to activation of the competence system and
establishment of intracellular infection (Rabinovich et al., 2012).
Prophage can also contribute to increased antibiotic resistance. Some cases are a result
of direct introduction of a resistance gene. An example of this is found in Streptococcus
pyogenes. MDR variants of S. pyogenes are predicted to be a result of acquired macrolide
resistance through introduction of a prophage-encoded erm (Hyder and Streitfeld, 1978).
Prophages influence antibiotic resistance in other models where the mechanisms of how they
do so remain unknown. For example, a study done by Wang et al. (2010) on E. coli K12 carrying
nine cryptic prophages (prophage unable to carry out a lytic infection) demonstrated that
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prophage contribute to antibiotic resistance. They conducted a curing experiment and found
that antibiotic sensitivity increased as the number of prophages decreased, with the strain
lacking all prophages being the most sensitive (Wang et al., 2010).
Toxin-antitoxin (TA) systems are abundant in bacteria and are associated with increased
virulence (Slayden et al., 2018; Harms et al., 2018). These genes may be encoded by the
bacterial genome but are also frequently encoded on mobile elements, including prophages
(Corray et al., 2017; Harms et al., 2018; Leplae et al., 2011; Dedrick et al., 2017; Harms et al.,
2017). However, the mechanisms by which they may increase bacterial virulence is largely
unexplored (Yao et al., 2018). TA systems consist of two genes that are typically adjacent and
transcribed together. The toxin interrupts cellular processes, often by interfering with or
degrading genetic material. The antitoxin binds and neutralizes the toxin (Wang et al., 2011).
Several functions of prophage-encoded TA systems have been identified. First, TA systems can
aid in bacterial persistence by altering the metabolic rate of the cell, allowing it to withstand
antibiotic exposure and other stressors (Wood, 2016). Additionally, prophage-encoded TA
systems have been shown to mediate biofilm formation in E. coli (Wang et al., 2011). TA
systems are also known to stabilize mobile elements such as plasmids and prophages. This is
the case with the ParE/CopA TA system encoded by the CP4So prophage found in Shewanella
oneidensis (Yao et al., 2018). It has also been demonstrated that prophage encoded TA systems
can confer abortive infection (Dedrick et al., 2017). Prophage-encoded TA systems are triggered
upon infection by another phage. The antitoxin is degraded, and the toxin induces altruistic
suicide of the cell. Sacrificing the cell prevents lytic phage proliferation, thereby protecting the
remaining bacterial population (Fineran et al., 2009).
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One or more prophage/prophage-like elements have been identified in sequenced
pathogenic mycobacterial strains; however, their roles remain to be fully characterized (Fan et
al., 2014). All strains of M. tuberculosis carry prophage Rv1, Rv2, or both (Fan et al., 2015).
M. bovis BCG, the vaccination strain, lacks these prophages due to deletions, and interestingly,
are unable to cause infections in humans. Work done by Fan et al. (2015) demonstrated that
several prophage genes are upregulated in M. tuberculosis during both nutrient starvation and
oxygen depletion. The mechanism of how these genes contribute to fitness has yet to be
identified but it makes sense that they play a role in stress adaptation of mycobacterial
intracellular pathogens (Fan et al., 2015).
1.6 Mycobacterium chelonae as a model for studying the role of prophage in pathogenic
mycobacteria
M. chelonae, a member of the M. abscessus/M. chelonae complex, is a rapidly growing
opportunistic human pathogen (Jaen-Luchoro et al., 2016). While it is primarily known as a
cause of mycobacteriosis in marine organisms due to its high abundance in water systems, it is
also a common cause of skin and soft tissue infections in humans (Jacobs et al., 2009). This is
especially prevalent in healthcare settings, where M. chelonae is isolated from post-surgical
wounds, implants, catheters, and dialysis ports (Jaen-Luchoro et al., 2016). It is also responsible
for corneal infection (de Moura et al., 2014). M. chelonae rarely causes lung or disseminated
disease, but it is possible in high-risk groups, including CF patients (Jaen-Luchoro et al., 2016).
The wild-type M. chelonae genome (CCUG 47445) spans 5,029,817 bp, contains 4,726
predicted coding sequences, and has a GC content of 64% (Jaen-Luchoro et al., 2016). It is a
very close relative of the prevalent human pathogen, M. abscessus, sharing more than 80%
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sequence identity at the protein-coding level. In fact, M. abscessus was previously misidentified
as M. chelonae due to nearly identical biochemical and morphological features. M. abscessus
was not recognized as a separate species until 1992 (de Moura et al., 2014).
Despite the homology and identical biosafety level (BSL-2) between the two species, M.
chelonae is safer to work with, making it an ideal pathogenic mycobacterial model in a
laboratory setting. The optimal growth temperature of M. chelonae is 30˚C, and it cannot grow
at 37˚C (the internal temperature of the human body), providing an explanation as to why it is
the causative agent of primarily superficial infections (Johansen et al., 2020). M. chelonae is a
fast-growing model organism relative to other mycobacteria, with a generation time of
approximately 5 hours. While it has a similar antibiotic resistance profile to M. abscessus, M.
chelonae lacks erm, making it susceptible to macrolides and therefore providing an effective
treatment option (Nash et al., 2009). In addition, M. chelonae is able to infect both murine and
human macrophage cell lines, as well as zebrafish, making both in vitro and in vivo studies
possible (Whipps et al., 2008).
M. chelonae is also an ideal model for studying the role of prophage in pathogenic
mycobacteria. It carries a naturally occurring cluster MabR prophage named McProf that has
been identified in clinical isolates of M. abscessus and is also susceptible to infection by
mycobacteriophage that include both M. abscessus and M. tuberculosis in their host ranges
(Dedrick et al., 2021).
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CHAPTER 2
CHARACTERIZING THE ROLE OF PROPHAGE ON WHIB7 EXPRESSION AND ANTIBIOTIC
RESISTANCE IN MYCOBACTERIUM CHELONAE
This chapter is a modified version of the following manuscript: Cushman J, Freeman E,
McCallister S, Schumann A, Hutchison KW, Molloy SD. (2021) Increased whiB7 expression and
antibiotic resistance in Mycobacterium chelonae carrying two prophages. BMC Microbiology,
21(176) doi: 10.1186/s12866-021-02224-z
2.1 Chapter Summary
Mycobacterium abscessus is the most intrinsically antibiotic-resistant species known. It is
the causative agent of lung infections that disproportionately affect immunocompromised
individuals. These characteristics make M. abscessus infections difficult to treat, with a success
rate of only 45% (Griffith, 2019; Johansen et al., 2020). While some extensively resistant
isolates are caused by mutations in drug targets, others appear to be a result of increased
intrinsic drug resistance (Guo et al., 2020). Common among pathogenic mycobacteria is the
presence of integrated viral genomes (prophage) that are known to contribute to fitness and
antibiotic resistance in other pathogens but whose roles are largely unknown in mycobacteria
(Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull, 2002).
We have demonstrated that the presence of an M. abscessus cluster R prophage, McProf, in
M. chelonae ATCC®35752 increased resistance to antibiotics such as amikacin, relative to
strains lacking the prophage. The presence of McProf also enhances amikacin resistance in
response to sub-lethal concentrations of antibiotics, or other cellular stresses such as infection
by a second phage, BPs. Relative to strains carrying only one of the prophages or no prophage,
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the strain carrying two prophages, BPs and McProf, had the highest amikacin resistance. This
strain also showed increased expression of the transcriptional activator, whiB7, which promotes
expression of intrinsic antibiotic resistance genes (Morris et al., 2005; Burian et al., 2012). This
work suggests that prophages play a role in increasing intrinsic antibiotic resistance and stress
adaptation in pathogenic mycobacteria. Given that most pathogenic mycobacteria carry one or
more prophages and encounter drug gradients in tissues during infection, characterizing how
prophages regulate antibiotic resistance genes and adaptation to stresses will provide insight
for developing more effective therapies for mycobacterial diseases.
2.2 Introduction
Prophage (integrated viral genomes) are major drivers of bacterial virulence and
antibiotic resistance in bacteria, yet the mechanisms of prophage-mediated antibiotic
resistance are unknown (Wang et al, 2010; Wang et al., 2016). Prophages are common in
mycobacteria, including clinical isolates of emerging non-tuberculosis pathogenic mycobacteria,
Mycobacterium avium and M. abscessus (Fan et al., 2014; Glickman et al., 2020). M. abscessus
is the causative agent of lung infections that disproportionately affects immunocompromised
individuals and is one of the most intrinsically antibiotic-resistant species known (Griffith, 2019;
Johansen et al., 2020). Extensively resistant isolates share increased expression of conserved
mycobacterial intrinsic antibiotic resistance genes such as whiB7, making drug treatment
challenging (Griffith, 2019; Guo et al., 2020). Understanding how intrinsic antibiotic resistance
genes are regulated in pathogenic mycobacteria would provide opportunities to develop novel
and more effective treatment approach (Burian et al., 2018; Guo et al., 2020).
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Currently, the only effective treatment option is combination therapy of amikacin (AMK)
and clarithromycin (CLA), along with an injectable antimicrobial such as cefoxitin, for as long as
2 years with harsh side effects (Hurst-Hess et al., 2017). Recent efforts in sequencing of clinical
M. abscessus isolates determined that mutations in the 23S rRNA gene, rrl, and in the erm
gene, which confers macrolide (e.g. clarithromycin) resistance, are typically associated with
elevated CLA resistant phenotypes but did not account for all the clarithromycin resistant
phenotypes (Guo et al., 2020). Consistent among all clarithromycin-resistant isolates was
elevated expression of genes in the whiB7 regulon, including the transcription factor whiB7 and
its target genes such as drug efflux pumps and antibiotic resistance genes, erm and eis (Burian
et al., 2013; Hurst-Hess et al., 2017; Guo et al., 2020). These latter genes confer macrolide and
aminoglycoside resistance, respectively. Likewise, in AMK-resistant isolates of M. abscessus
there is typically a 10-fold increase in whiB7 expression relative to AMK susceptible strains (Wu
et al., 2019).
whiB7 is conserved across all mycobacteria, including pathogenic and non-pathogenic
species such as M. tuberculosis, M. abscessus, M. chelonae and M. smegmatis (Morris et al.,
2005; Burian et al., 2012). whiB7 is upregulated in the presence of environmental stressors,
including the intracellular environment of a macrophage and exposure to subinhibitory drug
concentrations, but the cause of upregulation in extensively resistant M. abscessus is not well
understood (Morris et al., 2005; Burian et al., 2012). Characterizing the pathways that lead to
increased whiB7 expression and intrinsic drug resistance in pathogenic mycobacteria will be
important for identifying new targets for novel drug development (Nessar et al., 2012; Dheda et
al., 2018).
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Prophages are present in most bacterial pathogens and contribute to virulence and
antibiotic resistance (Brussow et al., 2004; Wang et al., 2016). In some models, the role and
mechanism of prophage impact is clear. E. coli 0157:H7 causes enterohemorrhagic disease and
is pathogenic due to a toxin encoded by the Stx prophage (Kaper et al., 2004). In other models,
the role is of prophage clear, but the mechanism is not understood. E. coli K12 carries 9 cryptic
prophages (transcriptionally active prophage that cannot carry out lytic infections) (Wang et al.,
2010). Wang et al. (2010) showed that as the number of prophages decreased through a series
of curing experiments, so did resistance to antibiotics. The strain lacking all prophages was
most susceptible to drugs. Toxin/antitoxin (TA) systems encoded by prophage are also known
to increase resistance and persistence in the presence of antibiotics. In E. coli, prophageencoded TA pair RalR/RalA increases resistance to broad-spectrum fosfomycin and the RelE
toxin of prophage Qin leads to persistence in the presence of ciprofloxacin, ampicillin and
tobramycin (Christensen et al., 2001; Guo et al., 2014; Neubauer et al., 2009). The majority of
mycobacterial pathogens also carry prophage, and they are hypothesized to play a role in
virulence yet remain largely uninvestigated (Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull,
2002). However, it has been shown that removal of prophage from M. tuberculosis renders it
nonpathogenic (Fan et al., 2015). This suggests that mycobacterial prophages are necessary for
the success of their pathogenic hosts.
In this study we examine the impact of two mycobacteriophages on intrinsic antibiotic
resistance and whiB7 expression in the non-tuberculous mycobacterial pathogen, M. chelonae,
a member of the M. abscessus/chelonae complex. The disease caused by M. chelonae, mainly
soft tissue and disseminating infections, differs from that of M. abscessus; however, the whiB7-
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dependent mechanisms of intrinsic resistance are conserved across all mycobacteria, including
M. chelonae (Morris et al., 2005; van Ingen et al., 2009). Additionally, M. chelonae shares 103 of
the 128 genes belonging to the whiB7 regulon in M. abscessus (Hurst-Hess et al., 2017). We
identified a naturally occurring prophage in M. chelonae that also occurs in the sequenced
genomes of at least 25 clinical isolates of M. abscessus (Molloy, Unpublished). We characterized
the genome of the M. chelonae prophage, McProf, and created a cured strain that lacks
prophage. Antibiotic resistance and gene expression of this strain was compared to that of M.
chelonae carrying a single or multiple prophages.
2.3 Materials and Methods
2.3.1. Bacterial and viral strains
Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas,
VA) was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. Tween 80
was excluded from bacterial cultures used in minimum inhibitory concentration and phage
infection assays. The wildtype strain of M. chelonae carries a naturally occurring prophage,
McProf, and will be referred to as M. chelonae (McProf). Kanamycin was used as a selective
measure for recombinant strains at a concentration of 250 μg mL-1 in liquid and solid media.
Competent E. coli DH5 cells were prepared by New England Biolabs, (Ipswich, MA) and grown
in Luria broth base, Miller (BD) supplemented with 50 μg mL-1 of kanamycin at 37˚C with
shaking at 230 RPM for propagation of plasmids. Bacterial strains used in this study are listed in
Table 2.1. Plasmids used in this study are listed in Table 2.2.
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Mycobacteriophage BPs was obtained from the Hatfull Laboratory and cultivated by plaque
assay using M. chelonae (McProf) or M. smegmatis MC2155 (Sampson et al., 2009). Serially
diluted phage samples were incubated for 15 min at room temperature in 0.5-mL aliquots of
late log phase bacteria. Aliquots were plated in 4.5 mL of 0.45% 7H9 top agar onto 7H10 agar
plates. High titer phage lysate stocks were generated by flooding bacterial lawns with nearly
confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1 mM CaCl2, 68.5 mM
NaCl). Viral strains used in this study are listed in Table 2.1.

Table 2.1 Bacterial and viral strains used in this study.
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Table 2.2 Plasmids used in this study.

2.3.2 Curing M. chelonae WT of its naturally occurring prophage
Mycobacterial expression vector, pST-KT (Parikh et al., 2013) carries a tetracyclineinducible promoter and kanamycin resistance gene. Curing M. chelonae (McProf) of its naturally
occurring prophage was achieved by overexpression of the McProf excision (xis) gene (McProf
gp5). pST-KT was digested with BamHI and HindII to linearize the vector, removing a 67-bp
fragment according to the manufacturer’s recommendations (New England Biolabs, Ipswich,
MA). Linearized vector was purified on a DNA clean-up column (NEB). An overexpression vector
was constructed by cloning a 292-bp G-block (Integrated DNA Technologies, Coralville, IA) that
included 27 bp and 24 bp of plasmid sequences that flank the 5’ and 3’ ends of digested vector
respectively, and an internal sequence that corresponds to the McProf gp5 ORF (3,169 – 3,405
bp) into M. chelonae (McProf) via Gibson Assembly (NEB). Resulting plasmid was transformed
into competent E. coli DH5 according to the manufacturer’s recommendations and plated on
selective L agar supplemented with 50 µg mL-1 of kanamycin (KAN). Recombinant plasmid,
referred to as pST-KT_xis was propagated in E. coli DH5 and sequenced to ensure presence of
xis.
pST-KT_xis was electroporated into competent M. chelonae (McProf) according to de
Moura et al. (2014) and PCR screened for presence of the plasmid (Table 2.3). Briefly,
electrocompetent M. chelonae cells were prepared by washing with ice-cold 10% glycerol four
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times. Plasmid DNA in 500 ng quantities were electroporated with 100 µL of electrocompetent
M. chelonae in 0.2-cm gap cuvettes. A sample of electrocompetent cells lacking plasmid DNA
served as a negative control. Electroporation was carried out in a single pulse at 2.5 kV, 25 mF,
1,000 Ω. Cells were suspended in 900 µL of room-temperature 7H9-OAD and incubated at 30˚C
with shaking for 4 h prior to plating on 7H10-OAD agar plates supplemented with 250 µg mL-1 of
KAN. Transformant colonies were PCR screened for presence of the plasmid (Table 2.3).
The recombinant strain was grown for 48 h at 30˚C with shaking and sub-cultured to an
optical density of 0.05 measured at a wavelength of 600 nm (OD 600). Cultures were then grown
to an optical density of 0.6 and treated with 500 g mL-1 of anhydrotetracycline (ATc) prepared
in dimethyl sulfoxide (DMSO) or an equal volume of DMSO before incubating for an additional
72 h at 30˚C with shaking. A 0.5-mL sample from treated and mock-treated cultures was
harvested, serially diluted, and plated in 100-L volumes onto 7H10-OAD supplemented with
250 g mL-1 of KAN. Plates were then incubated for 5 d at 30˚C. Bacterial colonies were lysed
and PCR screened for loss of McProf using a set of four primers that amplify either attL and attR
sites (indicating integrated prophage) or attB and attP sites (indicating excised prophage)
(Table 2.3). PCR products showing intact an intact attB site were sequenced to confirm
complete loss of prophage sequence. The resulting cured strain is referred to as M. chelonae
(∆McProf) (Table 2.1).
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Table 2.3 Standard PCR primers used in this study.

2.3.3 McProf genome annotation
Phaster (Arndt et al., 2016) was used to identify the McProf prophage region within the
M. chelonae genome. Phage attachment sites, attL and attR, were determined using DNA
Master (http://cobamide2.bio.pitt.edu) to yield genome end sequences. The phage genome
was annotated using DNA Master and the Phage Evidence Collection and Annotation Network
(PECAAN) (https://pecaan.kbrinsgd.org/index.html). An initial auto-annotation was performed
using GeneMark and Glimmer to identify ORFs and gene start coordinates (Borodovsky et al.,
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2003; Delcher et al., 1999). Annotation results were validated by manual inspection. Predicted
gene functions were determined by Basic Local Alignment Search Tool (BLASTand HHpred
analysis (Altschul et al., 1990; Soding et al., 2005). A genome map was generated in Phamerator
using the McProf_DB database (Cresawn et al., 2011).
2.3.4 Isolation of lysogenic strains
To generate BPs lysogen strains (Sampson et al., 2009), either M. chelonae (McProf) or
M. chelonae (∆McProf) was serially diluted and plated in 4.5 mL of 7H9 top agar onto 7H10OAD agar plates. Plates were treated or not treated with 109 plaque forming units (PFUs) of
BPs. Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in liquid culture
to test for phage particle release and superinfection immunity. Efficiency of lysogeny was
calculated by dividing the number of colonies on virus-treated plates by the number of colonies
on non-treated plates and multiplying by 100 to yield a percentage.
Genomic DNA was extracted from the M. chelonae (BPs, McProf) double lysogen and
sent to Jackson Laboratory for sequencing (Genome Technologies at Jackson Laboratory, Bar
Harbor, ME). Whole genome libraries were prepared and sequenced on a 2x150-bp MiSeq run.
The presence of the BPs prophage was confirmed through reads that did not align to the
bacterial reference genome. Primers were designed to PCR amplify BPs attachment sites, attL
and attR, to confirm prophage integration for continued cultivation of lysogen strains (Table
2.3). Lysogen strains carrying the BPs prophage or BPs and McProf prophages are referred to as
M. chelonae (BPs) and M. chelonae (BPs, McProf) respectively (Table 2.1).
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2.3.5 RNA isolations
Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at
an OD600 of 1.0. Samples were harvested into 6-mL of RNAProtect Bacteria Reagent (Qiagen,
Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. A first DNase
(Qiagen) treatment was performed on the columns. RNA was eluted in 50 L of hot nucleasefree water before undergoing a second DNase treatment using the Turbo DNA-Free Kit (Thermo
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the
RNA FlashGel System (Lonza, Rockland, ME) according to the manufacturer’s instructions.
Experiments involving acivicin (ACI) or amikacin (AMK) treatment prior to harvest were
completed with the following modifications to the previously described procedure. ACI-treated
samples were grown to an OD600 of 0.7 and treated with 75 M of drug for 3 h prior to harvest.
AMK-treated samples were grown to an OD600 of 0.9 and treated with 16.7 M of drug for 1 h
prior to harvest. Untreated control samples were incubated for an equal amount of time prior
to harvest for both experiments. In addition, 2-mL PowerBead Pro tubes (Qiagen) were used for
homogenization.
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2.3.6 RNAseq and read mapping
RNA underwent quality control analysis, library preparation, and paired end sequencing
on an Illumina HiSeq 2500 at the Delaware Sequencing and Genotyping Center (Newark, DE).
Samples were run on two lanes with 51-bp read lengths. Raw data files were uploaded the
Galaxy server at usegalaxy.org (Afgan et al., 2018). Read files were concatenated, FastQC was
used to assess quality, and reads were trimmed using Trim Galore! according to FastQC output
(Andrew, 2010; Kreuger, 2019). Trim Galore! parameters allowed for reads with a minimum
quality score of 30, 9-bp 5’ end trim, and 1-bp 3’ end trim to be kept. Due to incomplete rRNA
depletion prior to sequencing, rRNA reads were computationally removed through alignment to
the M. chelonae rRNA operon using Bowtie2 and unaligned reads were retained (Longmead et
al., 2012). This left an average of 2,280,954 reads per sample for M. chelonae (McProf) and
2,484,260 reads per sample for M. chelonae (BPs, McProf). The average read depth for both
strains was 40. Reads were then quantified and aligned to the M. chelonae transcriptome
(coding transcript fasta file obtained from GenBank) using Salmon (Patro et al., 2017).
Alignment parameters were set to correct for the high GC content of mycobacterial genomes
and strand specificity, with mate pair 1 coming from the reverse strand.
Salmon outputs were used to determine differential gene expression using the R
statistical package, DESeq2 (Love et al., 2014). Significant regulation was identified by a Log2
fold change (Log2FC) greater than 1 and a maximum False Discovery Rate (FDR) of 0.05. Genes
with low expression were defined as those with less than 10 reads mapped and were
subsequently removed. M. chelonae gene functions are poorly characterized. To overcome this,
an ortholog table was generated based on genes in the M. smegmatis, M. abscessus, and M.
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tuberculosis genomes using the OrthoDB pipeline (Zdobnov et al., 2014). This, in combination
with blastP via MyocBrowser and HHpred, allowed for significantly upregulated predicted
virulence genes in M. chelonae to be identified (Kapopoulou et al., 2011; Zimmerman et al.,
2018).
2.3.7 cDNA synthesis and qRT-PCR
cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting
samples 1:6 in 10 mM Tris.
Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100bp region with the gene of interest using Primer3 (Table 2.4). qRT-PCR assays were carried out
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted
1:6), and PerfeCTa SYBR Green Supermix (Quantabio) according to the manufacturer’s
instructions. Positive and no-template controls were included in each assay. Reactions were run
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT
method (Livak et al., 2001).

31

Table 2.4 qRT-PCR primers used in this study.

2.3.8 Minimum inhibitory concentration assays
Minimum inhibitory concentration assays were performed according to Burian et al.
(2012) and Ramon-Garcia et al. (2013). Cultures were grown in 7H9-OAD supplemented with
0.05% Tween 80 at 30˚C with shaking and sub-cultured such that overnight incubation resulted
in an OD600 of 0.1 – 0.3. Cultures were diluted to a density of 105 cells ml-1 and applied in 50-L
volumes to wells of a 96-well plate containing 50 l of 7H9 media with antibiotic concentrations
that varied by 2-fold dilutions across the plate. Amikacin (AMK) assays involving an acivicin (ACI)
pre-treatment were carried out by diluting cultures to a density of 105 cells mL-1, treating with
75 μM of ACI, and incubating for 3 h. Media containing varying 2-fold concentrations of
antibiotics were applied to plates in 50-L volumes. AMK assays were performed at
concentrations ranging from 512 – 4 g mL-1. Tobramycin (TOB) assays were performed at
concentrations ranging from 64 – 0.5 g mL-1. Tetracycline (TET) and clarithromycin (CLA)
assays were performed using 2-fold dilutions of antibiotic concentrations ranging from 64 – 0.5
and 3 – 0.02 g mL-1 respectively. Clarithromycin was prepared in DMSO, and therefore DMSO
was included in all wells of CLA assays. Each strain was applied in replicates of six at each drug
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concentration. Bacteria was applied in the absence of drugs in replicates of 16 as a control.
Additionally, wells containing only media plus drug at each concentration were included to
serve as an absorbance blank. Inoculated plates were sealed with porous adhesive culture plate
films (VWR International, Radnor, PA), wrapped with parafilm and incubated at 30°C for 2 d. A
solution of 25% Tween 80 and AlamarBlue (Bio-Rad) was added to each well in 25- and 1-L
volumes respectively, incubated at 30˚C for 1 d, and OD measured at 570- and 600 nm. Percent
viability of cells was calculated as the percent difference in reduction between antibiotictreated cells and untreated cells according to the manufacturer’s instructions. Each assay was
replicated in a minimum of two independent experiments.
2.4 Results
2.4.1 Co-habitating prophages result in increased aminoglycoside antibiotic resistance in M.
chelonae
The wildtype M. chelonae (ATCC® 35752) carries a naturally occurring 67,657-bp
prophage that we have named McProf. To determine how prophages impact gene expression
and the antibiotic resistance phenotype of M. chelonae we added a second prophage. We
identified three mycobacteriophages capable of infecting M. chelonae, Muddy, WildCat and
BPs, of which only BPs is known to be temperate (Hatfull et al., 2010; Hatfull, 2013; Sampson et
al., 2009). A double lysogen of M. chelonae was created from the WT M. chelonae strain using
the cluster G mycobacteriophage, BPs (Sampson et al., 2009). BPs integrates into an attB site
located within the 3' end of the host tRNA-Arg gene (BB28_RS01100), that is similar to the BPs
attB site in M. smegmatis (Msmeg_6349) (Sampson et al., 2009). BPs lysogens of the M.
chelonae WT strain (BPs, McProf) appear to be more stable than BPs lysogens of M. smegmatis.
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Lysogens form at a higher efficiency in M. chelonae WT (25%) compared to that in M.
smegmatis (5%) and release fewer particles into cell culture supernatant (104 – 105 PFUs mL-1
compared to 1010 PFUs mL-1) (Sampson et al., 2009; Broussard et al., 2013).
We tested susceptibility of M. chelonae (BPs, McProf) to aminoglycosides, AMK and
TOB, as well as TET and CLA compared to M. chelonae (McProf) by minimum inhibitory
concentration (MIC) assay to identify whether presence of an additional prophage alters the
antibiotic resistance phenotype. The presence of the second prophage, BPs, significantly
increased resistance to both aminoglycosides (Table 2.5). There was not a consistent significant
difference in resistance to TET. As a positive control, we exposed the M. chelonae (McProf)
strain to sub-inhibitory concentrations of acivicin (ACI), a known inducer of intrinsic resistance
in mycobacteria (Hurst-Hess et al., 2017). As expected, ACI significantly increased the resistance
of M. chelonae (McProf) in both the AMK and TOB assays (Table 2.5). ACI treatment did not
significantly alter TET or CLA resistance of M. chelonae (McProf).
Table 2.5. Minimum inhibitory concentrations for each M. chelonae strain as determined by the
lowest drug concentration that completely inhibited cell growth.

We also determined the viability of the strains after antibiotic treatment by adding
AlamarBlue to the wells to detect metabolic activity (Figure 2.1). There was a statistically
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significant difference in viability between the double lysogen and WT strains treated with 64 g
mL-1 AMK and 8 g mL-1 TOB. We noted a slight increase in viability of the WT strain at 8 g mL1

of TOB; however, there was no evidence of growth at this concentration of TOB. The WT

strain treated with ACI in both the AMK and TOB assay had the highest viability at these drug
concentrations. Some background reduction of AlamarBlue was observed for both strains at
doses higher than the observed MIC; however, there was no growth detected in those wells.
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Figure 2.1 Percent viability of M.
chelonae (McProf) and M. chelonae
(BPs, McProf) upon aminoglycosde
treatment. Percent viability of M.
chelonae carrying single prophage
McProf (MP) and two prophages, BPs and
McProf, in the presence of varying
concentrations of a. AMK and b. TOB. As
a positive control, single McProf lysogens
were treated with 75 μM acivicin (Aci) a
known inducer of whiB7. Graphs
represent average values  SE of the
mean with n=6. The optical density was
measured at 570- and 600 nm after
addition of 1 μL of AlamarBlue and the
percent difference in reduction between
antibiotic-treated cells and untreated
cells was calculated. Mean percent
reduction by M. chelonae that are
statistically significant are indicated by an
Asterix (Wilcoxon rank sum, p<0.05).
Data is representative of three
independent experiments.

2.4.2 Isolation and characterization of BPs single lysogen and non-lysogen strains of M.
chelonae
To better understand how the presence of the second prophage increases antibiotic
resistance, we generated a strain of M. chelonae that contains no prophage (M. chelonae
(McProf)) and from that, a single BPs lysogen of M. chelonae (Table 2.1). We removed the
McProf prophage by creating a recombinant strain of M. chelonae (McProf) that overexpresses
the McProf excise gene (gp5) from an inducible mycobacterial expression plasmid (Table 2.2)
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(Parikh et al., 2013). We identified ATc-induced bacterial colonies that had an intact attB site by
PCR amplification and sequencing (Table 2.3), indicating loss of the prophage and an active
integrase system. To determine if McProf phage particles are released from M. chelonae
(McProf) cells through spontaneous induction, concentrated culture supernatants were plated
onto lawns of the newly acquired non-lysogen strain (McProf), but we were unable to detect
plaques. PCR analysis of M. chelonae (McProf) culture supernatants also failed to detect the
McProf attP sequence, which would have indicated the presence of either excised McProf
genome or linear McProf genome in phage particles. It is possible that there is a mutation that
we were not able to identify that prevents McProf from carrying out a successful lytic infection.
Alternatively, M. chelonae may not be the natural host and McProf is capable of lytically
infecting other mycobacterial hosts.
The non-lysogen strain of M. chelonae (McProf) was used to isolate single lysogens of
BPs. Although we were able to isolate BPs lysogens in the non-lysogen strain of M. chelonae,
they are less stable than BPs lysogens formed in the WT strain (McProf) and comparable to
lysogens formed in M. smegmatis (Sampson et al., 2009; Broussard et al., 2013). We
determined efficiency of lysogeny to be 5% and particle release from lysogen culture
supernatant was 1010 PFU mL-1. This contrasts an efficiency of 25% and particle release of 105
PFU mL-1 observed in M. chelonae (BPs, McProf), suggesting that McProf may play a role in
lysogen stabilization
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2.4.3 Strains of M. chelonae carrying McProf demonstrate increased resistance to
aminoglycosides
To determine the roles of prophages BPs and McProf in the increased resistance
observed in the double lysogen, we determined the MIC and viability of double (BPs, McProf)
and single (BPs or McProf) M. chelonae lysogens relative to non-lysogen cells (McProf) in the
presence of varying levels of AMK, TOB, TET and CLA (Table 2.5 and Figure 2.2). The presence
of the naturally occurring prophage, McProf, significantly contributes to AMK resistance in M.
chelonae in the presence and absence of ACI treatment (Table 2.5). The WT strain carrying
McProf alone had a higher MIC for AMK (64 g mL-1) relative to the non-lysogen strain
(McProf) (MIC of 32 g mL-1) (Burian et al., 2012; Hurst-Hess et al., 2017). Treatment of these
two strains with ACI increased the MIC for both strains; however, the MIC for ACI-treated WT
(McProf) strain was two-fold higher than that of the ACI-treated non-lysogen (McProf) strain
(Table 2.5) The presence of a second prophage, BPs, also increases resistance to AMK, with
bacterial growth at doses as high as 64 g mL-1. Although the double lysogen had the same MIC
as the ACI-treated WT strain (128 g mL-1) (Table 2.5), the cell viability of the ACI-treated WT
strain was statistically higher than that of the double lysogen (Figure 2.2a). BPs alone had no
effect on AMK resistance suggesting that BPs only increases AMK resistance through an
interaction with the naturally occurring prophage, McProf.
The presence of the prophages McProf and BPs also altered TOB resistance in M.
chelonae (Table 2.5 and Figure 2.2b). The WT (McProf) strain did not have a higher TOB MIC
than the non-lysogen strain (8 g mL-1), but in the presence of ACI, the MIC for WT (McProf)
strain increased two-fold (16 g mL-1), whereas the MIC for the non-lysogen (McProf) strain
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remained 8 g mL-1. It is possible a difference would be detected at TOB doses between 4- and
8 g mL-1. The TOB MIC for the double lysogen (BPs, McProf) was the same as that for the ACItreated WT (McProf) strain; however, the viability for ACI-treated WT (McProf) strain was
significantly higher than that of the double lysogen at 8 g mL-1 (Table 2.5 and Figure 2.2b).
Since M. chelonae lacks erm, which confers intrinsic macrolide resistance (Nash et al.,
2009), we anticipated that there would be minimal change in CLA resistance regardless of
prophage treatment. We observed that prophages had little effect on CLA resistance, although
ACI treatment did increase resistance in M. chelonae (McProf) and M. chelonae (∆McProf).
Additionally, TET resistance was largely unaltered by the presence of prophages nor by ACI
treatment (Table 2.5).
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Figure 2.2 Percent viability of M.
chelonae strains upon aminoglycoside
treatment. Percent viability of M.
chelonae carrying single prophage
McProf, two prophage, BPs and
McProf, no prophage, or single BPs
prophage in the presence of varying
concentrations of a. AMK and b. TOB.
As a positive control, single McProf
lysogens and non-lysogen cultures
were treated with 75 μM acivicin (Aci),
a known inducer of whiB7. Graphs
represent average values  SE of the
mean with n=6. The optical density of
was measured at 570- and 600 nm after
addition of 1 μL of AlamarBlue and the
percent difference in reduction
between antibiotic-treated cells and
untreated cells was calculated. Mean
percent reduction by M. chelonae that
are statistically significant are indicated
by an Asterix (Wilcoxon rank sum,
p<0.05). Data is representative of three
independent experiments.

2.4.4 Prophage McProf enhances AMK resistance in response to sub-inhibitory concentrations
of antibiotics.
Because the M. chelonae (McProf) strain treated with ACI had higher AMK resistance
than the non-lysogen strain treated with ACI, we wondered if the presence of prophage McProf
enhances the effect of sub-inhibitory concentrations of antibiotics on AMK resistance. To
determine the interaction between ACI and the presence of one or both prophages, we treated
all four lysogen and non-lysogen strains with sub-inhibitory concentrations of ACI and repeated
the AMK resistance assay. The presence of McProf increases the effect of ACI on AMK
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resistance compared to the non-lysogen whereas the BPs prophage alone does not (Table 2.5
and Figure 2.3). The double lysogen treated with ACI did not have a higher MIC than the WT
(McProf) strain treated with ACI; however, cultures of the ACI-treated double lysogen (BPs,
McProf) did consistently have a statistically higher viability than that of ACI-treated WT
(McProf) strain at AMK doses of 64 g mL-1. The presence of BPs and ACI appear to interact
with McProf to increase AMK resistance.

Figure 2.3 Percent viability of M. chelonae strains upon AMK treatment in the presence and
absence of ACI. Percent viability of M. chelonae carrying no prophage McProf (McMP), BPs
prophage (Mc+BPsMP), prophage McProf (Mc+MP) or both prophage BPs and McProf
(Mc+BPs+MP) in the presence of varying concentrations of amikacin. To determine if the presence
of each prophage interacts with sub-inhibitory concentrations of antibiotics, each strain was
treated or not treated with 75 μM acivicin (Aci). Graphs represent average values  SE of the mean
with n=3. The optical density of was measured at 570- and 600 nm after the addition of 2 μL of
AlamarBlue and the percent difference in reduction between antibiotic-treated cells and
untreated cells was calculated. Data is representative of two independent experiments.
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2.4.5 Transcriptional activator, whiB7, is upregulated in double lysogens of M. chelonae
RNA was isolated from M. chelonae (McProf) and M. chelonae (BPs, McProf), and
RNAseq analysis performed to determine whether the presence of a second prophage (BPs)
influenced gene expression that could explain the increased antibiotic resistance observed in
the double lysogen strain. Strikingly, the presence of BPs in the wildtype strain altered
expression of 417 of 4,867 genes relative to M. chelonae (McProf). This indicated that 8.5% of
M. chelonae genes were differentially expressed in the presence of a second prophage,
including a variety of predicted virulence genes (Figure 2.4).
Figure 2.4 MA plot of M. chelonae
(BPs, McProf) gene expression. MA
Plot presenting the relationship
between average expression level
(mean of normalized counts) of M.
chelonae genes and their fold change
(log2fold change) in the double M.
chelonae lysogen (BPs, McProf)
relative to the WT strain (McProf).
Red indicates genes identified as
differentially expressed at an FDR of
0.05 or smaller.

The majority of the top-ranked genes in the double lysogen belonged to the whiB7
regulon, genes in M. tuberculosis with functions related to antibiotic resistance and increased
survival in macrophage (Tables 2.6 and 2.7) (Morris et al., 2005). Notably, the fifth most
upregulated gene was identified as transcriptional activator, whiB7 (BB28_RS17590), at a foldchange of 26.5. Analysis of the M. chelonae Whib7 peptide sequence showed characteristics of
whiB7 genes in mycobacteria, including a conserved iron sulfur cluster binding domain and C-

42

terminal AT-hook DNA binding domain (Burian et al., 2013; Hurst-Hess et al., 2017) (Figure 2.5).
Additionally, M. chelonae WhiB7 shares 95% peptide sequence identity with its M. abscessus
ortholog (MAB_3508c). M. chelonae contains 103 of the 128 genes belonging to the whiB7
regulon in M. abscessus, 30 of which are significantly upregulated in M. chelonae (BPs, McProf)
(Hurst-Hess et al., 2017). Multiple genes from the whiB7 regulon that were upregulated have
known roles in intrinsic antibiotic resistance, including GNAT acetyltransferases, eis1 and eis2
(BB28_RS05390 and BB28_RS22650 respectively), multi-drug efflux transporter, tap
(BB28_RS06750), and efflux pump, tetV (BB28_RS13560) (Table 2.7). Also included in this
regulon are additional GNAT acetyltransferases (BB28_RS23100 and BB28_RS01940) and ABC
transporters with ATP binding domains that likely function in drug resistance (Tables 2.6 and
2.7). In M. abscessus and M. tuberculosis, erm is part of the whiB7 regulon and provides
macrolide resistance but the gene is not present in the M. chelonae genome (Nash et al., 2009).
M. chelonae lacks this whiB7 regulon gene, but it does encode a newly discovered gene in the
whiB7 regulon, the ribosome splitting factor hflX (MAB_3042c), which is reported to contribute
to macrolide resistance in M. abscessus (Nash et al., 2009; Rudra et al., 2020). Expression of the
M. chelonae hflX was slightly elevated in double lysogens relative to the WT strain (McProf)
(BB28_RS14985; LogFC=2.8, FDR=8.4-33) but this did not result in significant changes in CLA
resistance in the double lysogen (Table 2.7). An additional 25 whiB7 regulon genes were
upregulated but had fold changes of less than 2.
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Figure 2.5 WhiB7 protein alignment. Clustal Omega alignment of the protein coding sequence
for WhiB7 in M. tuberculosis (MTb), M. smegmatis (MSMEG), M. abscessus (MAB), and M.
chelonae (MC). Highlighted regions represent conserved sequences typical of whiB7 genes.
The most highly regulated gene, with a 99-fold increase in expression, was annotated as
a flotillin protein with no known function (BB28_RS01845) (log2FC = 6.6, FDR = 6.4 –124) (Table
2.6). Several of the most down regulated genes in the lysogen include a padR-family
transcription factor (BB28_RS01835, Log2FC= -8.3, FDR = 1.4–10) and genes involved in glycerol
uptake (glpF, BB28_RS01835, Log2FC= -6.2, FDR = 4.5–06) and metabolism (glpK, BB28_RS01840,
Log2FC= -9.0, FDR = 1.1–12) (Table 2.6) (Ehrt et al., 2005). RNAseq data were validated by
performing qRT-PCR on two independent sets of RNA measuring relative expression of
upregulated (whiB7 and tap) and downregulated (glycerol kinase (glpK)) genes as indicated by
the RNAseq data (Figure 2.6).
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Figure 2.6 qRT-PCR verification of
RNAseq data. The average relative
expression levels of whiB7, tap, and glpK
in M. chelonae (BPs, McProf) (green bars)
relative to M. chelonae (McProf) (blue
bars) measured by SYBR Green qRT-PCR.
Genes were selected based on up- or
downregulation in RNAseq data to
validate results. RNA was isolated in
triplicate from cells at an OD600 of 1.0.
Graphs represent average values ±
standard error of the mean with n=3 and
are representative of two independent
trials. Means with different letters are
significantly different (Tukey’s HSD,
α=0.05).
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Table 2.6 Top 20 upregulated and downregulated genes in M. chelonae (BPs, McProf)
relative to M. chelonae (McProf).
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Table 2.7 whiB7 regulon genes upregulated in M. chelonae (BPs, McProf) relative to M.
chelonae (McProf).

2.4.6 Upregulation of whiB7 only occurs in M. chelonae (BPs, McProf)
To determine how the presence and absence of each prophage impacts whiB7
expression, RNA was isolated from each strain at an OD 600 of 1.0 and whiB7 mRNA levels were
measured by qRT-PCR in the BPs single lysogen, double lysogen (BPs, McProf), and non-lysogen
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(McProf) and compared to that of the WT strain (McProf) (Figure 2.7). Although whiB7
expression was slightly elevated in the non-lysogen (2-fold) and BPs single lysogen (4-fold)
strains relative to the WT strain (McProf), the dramatic increase in whiB7 expression (~40-fold)
only occurred in M. chelonae carrying both prophages (BPs, McProf). The elevated whiB7
expression occurred in the absence of known inducers of whiB7, such as ACI, which suggests
BPs-encoded gene products interact with prophage McProf, resulting in whiB7 induction. The
elevated expression of whiB7 in the double lysogen likely explains the increased resistance to
AMK and TOB in the absence of ACI treatment (Table 2.5 and Figure 2.4).
Figure 2.7 qRT-PCR analysis
of whiB7 expression in M.
chelonae strains. The average
relative expression levels of
whiB7 in M. chelonae carrying
McProf alone, BPs and
McProf, no prophage, and BPs
alone as measured with SYBR
Green qRT-PCR. Cultures
were grown to an OD600 of 1.0
before harvesting RNA in
triplicate. Graphs represent
average values ± standard
error of the mean with n=3
and are representative of two
independent trials. Means
with different letters are
significantly different (Tukey’s
HSD, α=0.05).
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2.4.7 Sub-inhibitory concentrations of ACI, but not AMK, increase whiB7 expression in M.
chelonae (BPs, McProf)
We were surprised that the M. chelonae (McProf) strain had the lowest expression of
whiB7 expression among the four strains given that it had higher AMK resistance, both in the
presence and absence of ACI, than the two strains that lack McProf. We reasoned this may be
due to whiB7-independent intrinsic resistance, such as cell wall permeability, and/or whiB7
induction in the presence of AMK, which is a more potent inducer of whiB7 than ACI (HurstHess et al., 2017). Likewise, we wondered if the heightened viability observed in the single and
double McProf lysogen strains in the presence of AMK and ACI was due to increased whiB7
expression. To assess this, we measured whiB7 expression in double, single, and non-lysogen
strains following a 3-h treatment with 75 M ACI or 1-h treatment with 16.7 M AMK (Figures
2.8 and 2.9).
ACI treatment resulted in increased whiB7 expression in all four strains relative to
untreated strains (Figure 2.8). Expression of whiB7 was highest in the double lysogen strain
(BPs, McProf) treated with ACI which correlates with the observed AMK resistance of this
strain. whiB7 expression in the single and non-lysogen strain increased with ACI treatment;
however, the relative levels of whiB7 expression did not correlate with AMK resistance (Figure
2.3a). Although the fold-increase of whiB7 in ACI-treated strains relative to control strains was
highest in the WT strain (McProf) (9.5-fold) whiB7 was lower than that of the ACI-treated BPs
single lysogen, which demonstrated lower AMK resistance.
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Figure 2.8 qRT-PCR analysis of
whiB7 expression in M. chelonae
strains in the presence and
absence of ACI treatment. The
average relative expression levels
of whiB7 in M. chelonae carrying
McProf alone, no prophage, BPs
alone, or BPs and McProf as
measured with SYBR Green qRTPCR. RNA was harvested in
triplicate from strains grown to
an OD600 of 0.7 before treating or
not treating with 75 μM ACI and
incubating for an additional 3 h.
The culture OD600 at time of
harvest was close to 1 but
differed slightly for each strain
and treatment. Graphs represent
mean ± SE with n=3. Letters
represent statistically significant
differences (Tukey’s HSD, α
=0.05).

Strains that lack the McProf prophage had the greatest increase in whiB7 expression in
response to AMK treatment. The non-lysogen and BPs single lysogen had 28- and 7-fold
increases in whiB7 expression in response to AMK treatment, respectively (Figure 2.9). AMK
had less of an effect on whiB7 expression in strains carrying McProf. AMK treatment resulted in
a 3.5-fold increase in whiB7 expression in the single McProf lysogen and no significant increase
in whiB7 expression in the double lysogen. It’s possible that AMK doesn’t result in strong
induction of whiB7 expression in the McProf-carrying strains due to cell wall permeability
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and/or efflux, and if so, this could also explain the AMK-resistant phenotypes observed in the
single McProf and double lysogen strains.

Figure 2.9 qRT-PCR analysis of
whiB7 expression in M.
chelonae strains in the
presence and absence of AMK
treatment.
The
average
relative expression levels of
whiB7 in M. chelonae carrying
McProf alone, no prophage,
BPs alone, or BPs and McProf
as measured with SYBR Green
qRT-PCR. RNA was harvested
in triplicate from strains
grown to an OD600 of 0.9
before treating or not treating
with 16.7 μM AMK and
incubated for an additional 1
h. Graphs represent mean ±
SE with n=3. Letters represent
statistically
significant
differences (Tukey’s HSD, α
=0.05).
2.4.8 Characterization of the McProf prophage
The McProf genome was characterized to uncover potential interactions between the
naturally occurring prophage and BPs in M. chelonae to increase whiB7 expression and
antibiotic resistance. McProf is 67,657 bp in length, spanning coordinates 1,521,426 –
1,589,648 in M. chelonae CCUG 47445. The genome encodes 98 putative genes, no tRNAs, and
has been annotated in its prophage format with the first gene located immediately adjacent to
attL (Figure 2.10). The McProf prophage is integrated into a leftward oriented tRNA-Lys
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(BB28_RS07905) and is flanked by 45-bp attachment sites, attL and attR (5’TGCGCCGTCAGGGGCTCGAACCCCGGACCCGCTGATTAAGAGTCA-3’).
Gp1 encodes a rightward transcribed tyrosine integrase, followed by a gene of unknown
function (gp2) and the predicted immunity repressor (gp3). Gp3 shares high sequence similarity
with immunity repressors identified in other mycobacteriophages, such as singleton DS6A, and
cluster K12 phages, DismalFunk, DismalStressor, Findley, Milly, and Marcoliusprime (Russel and
Hatfull, 2016). Gp4 and gp5 encode Cro (control of repressor’s operator) and excise respectively
and contain helix-turn-helix (HTH) DNA binding motifs characteristic of these genes. The McProf
genome follows the typical synteny of bacteriophage with genes involved in DNA replication
and metabolism oriented downstream of the integration cassette. Structural genes span gp51 –
82 and include a lysis cassette encoding lysin A, lysin B, and holin (gp76 -78 respectively).
Between the structural genes and the attR site is a region of genes that are typically expressed
during lysogeny, although many of these genes do not have a predicted function in McProf
(Dedrick et al., 2017). Genes within this region with predicted functions include an ADP-ribosyl
glycosylhydrolase (gp86), a HTH DNA binding protein (gp89), a membrane protein (gp90), an
AAA-ATPase (gp91), and a polymorphic toxin cassette (gp96 – 98).
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Figure 2.10 Phamerator map of the McProf genome. The coordinates of the McProf genome
are represented by the ruler. Genes are shown as colored boxes above (transcribed
rightwards) or below (transcribed leftward) the ruler. The map was generated using
Phamerator (Cresawn et al., 2011).

Of interest is the polymorphic toxin (PT) cassette on the rightmost arm of the McProf
genome, as it encodes proteins that are likely secreted by a mycobacterial Type 7 secretion
system (T7SS) expressed by M. chelonae (Esx3 or Esx4). HHpred analysis of gp98 suggests that it
encodes a 105-amino acid product consistent with T7SS proteins based on helical domains with
high similarity to characteristic WXG-100 motifs (Pallen, 2002). However, gp98 includes a SAG
motif that is slightly different from the conserved WXG motif. Gp97 appears to encode a 732amino acid polymorphic toxin. The C-terminus includes a toxin_43 motif (PF15604.6) with high
sequence similarity to Type 6 secretion system (T6SS) polymorphic toxin, TdeI. This toxin was
identified in Agrobacterium tumefaciens (Atu4350) and belongs to a family of proteins
exhibiting DNase activity characterized by a conserved HxxD catalytic domain in the C-terminus
(Ma et al., 2014). In addition, gp97 contains a WXG-100 motif in the N-terminus and a likely
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T7SS secretion signal, YxxxD/E, in the C-terminus (Daleke et al., 2012). Gp96 encodes a
predicted 216-amino acid Tdi-like immunity protein, which are known to be paired with Tdi
toxins to neutralize its activity. Gp96 includes the conserved domains characteristic of Tdi
proteins, GAD and DUF1851 (Figure 2.11) (Ma et al., 2014).

Figure 2.11 McProf ESX-like polymorphic toxin cassette. Graphical domain
organization of the McProf-encoded polymorphic toxin cassette (gp96 –
98).

2.4.9 Lysogenic gene expression profiles from the BPs and McProf prophage genomes.
To determine if the presence of BPs alters gene expression from the McProf prophage
genome, differential expression of McProf genes was examined between the WT strain
(McProf) and the double lysogen (BPs, McProf). None of the expressed McProf genes were
significantly differentially expressed in the presence of the BPs prophage (FC>1.99 and
FDR<0.05). Because there was no difference in expression profiles, we present below the
expression profile of only the McProf prophage from the M. chelonae WT (McProf) strain
(Figure 2.12b).
The immunity repressors from both the BPs (gp33) and McProf (gp3) genomes are
highly expressed during lysogeny of M. chelonae (Figure 2.12). The BPs genome also expresses,
gp58, a gene of unknown function that is part of a mycobacteriophage mobile element
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(MPME1) (Figure 2.12a) (Sampson et al., 2009). There are an additional 15 genes expressed at
varying levels from the McProf genome (Figure 2.12b). The integrase (gp1) is expressed at low
levels and is adjacent to a moderately expressed gene of no known function (gp2). There are
three reverse oriented genes, gp48 – 50, located between the HNH endonuclease (gp47) and
the small subunit terminase (gp51) and a small reverse oriented gene (gp56) adjacent to the
scaffolding protein with moderately and low expression, respectively. We were not able to
determine functions for these genes; however, gp46 and gp47 do have predicted membrane
domains. The remaining genes expressed from the McProf prophage genome are located
between the structural genes and attR and many do not have predicted gene functions,
including the most highly expressed McProf gene, gp84. There is also strong expression from
the gene cassette containing the putative WXG-100 family polymorphic toxin and immunity
protein (gp96 – 98). None of the expressed McProf genes were significantly differentially
expressed in the presence of the BPs prophage (FC>1.99 and FDR<0.05).
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Figure 2.12 Lysogenic gene expression profiles of BPs and McProf. Lysogenic gene
expression profiles of prophages a. BPs and b. McProf from the M. chelonae WT strain.
RNAseq profiles are shown for forward (blue) and reverse (red) DNA strands. Note that
in a. the sequence reads are mapped to the viral BPs genome rather than prophage
genome whereas in b. the sequence reads are mapped to the McProf prophage genome.
The number of reads mapped are on the y-axis and the genome maps are shown below.
Genes expressed from the McProf prophage genome in the double lysogen were not
significantly different from the WT strain and therefore the expression profile was not
included.
2.5 Discussion
Cases of NTM infections have been on the rise in recent decades (Johansen et al., 2020).
M. abscessus, a causative agent of pulmonary infections, has become a major health concern,
especially for immunocompromised individuals, due to extreme antibiotic resistance (Johansen
et al., 2020). Frontline antibiotics used to treat M. abscessus infections include CLA and AMK.
However, the bacteria encounter a drug gradient in tissues and often develop resistance during
the course of treatment (Guo et al., 2020). In many cases, resistance is caused by mutations in
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16S or 23S rRNA which confer resistance to AMK and CLA respectively, but do not account for
extensively resistant phenotypes in all isolates (Nessar et al., 2012). Additionally, induction of
the whiB7 regulon contributes to increased resistance and whiB7 expression is elevated in
extensively resistant strains of M. abscessus compared to those susceptible to treatment (Guo
et al., 2020). Elucidating the mechanisms that trigger upregulation of whiB7 could lead to more
effective therapies for extensively resistant mycobacterial infections.
We have demonstrated that the presence of prophages in mycobacteria contribute to
increased AMK and TOB resistance (Table 2.5 and Figure 2.4). This is similar to the effect
previously described in E. coli where strains lacking prophages were more sensitive to -lactam
(Wang et al., 2010). Interestingly, the McProf prophage alone appears to play a more significant
role, but addition of second prophage (BPs) amplifies the effect of McProf on antibiotic
resistance. Strains of M. chelonae carrying BPs only or no prophage were more susceptible to
AMK relative to those carrying McProf. Additionally, ACI treatment increased AMK and TOB
resistance in all strains, which makes sense because ribosome-targeting antibiotics induce
whiB7 expression and therefore increase intrinsic antibiotic resistance (Table 2.5 and Figure
2.5) (Morris et al., 2005; Burian et al., 2012). However, this effect was elevated in M. chelonae
(McProf) in AMK assays and further enhanced by presence of BPs compared to M. chelonae
(∆McProf), indicating that McProf plays a substantial role in mediating AMK resistance.
The dramatically higher whiB7 expression in the strain carrying both prophages (BPs,
McProf) likely contributes to the heightened AMK and TOB resistance observed in the double
lysogen (Figures 2.7 and 2.9; Tables 2.6 and 2.7). We observed high whiB7 expression in the
double lysogen in the absence of antibiotics or other conditions known to induce whiB7,
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revealing prophage as a novel mechanism of inducing whiB7 expression and intrinsic antibiotic
resistance. Also upregulated in the double lysogen are whiB7 regulon genes that can explain the
increased resistance to aminoglycosides AMK and TOB (Pryjma et al, 2017). The GNAT
acetyltransferase, eis2, and tap, a multidrug efflux pump, were each upregulated ~10-fold in
the double lysogen and confer resistance to aminoglycosides (Hurst-Hess et al., 2017; Ainsa et
al., 1998; Chen et al., 2012). 2-N-acetyltransferase AAC(2) also contributes to resistance to
TOB and AMK, however this gene (BB28_RS22055) was not significantly upregulated in our data
set (Luthra et al., 2018). It is possible that other N-acetyltransferases (BB28_RS23100,
BB28_RS01940, BB28_RS14560), aminoglycoside phosphotransferases (BB28_RS12685), or
potential efflux pumps (BB28_11540) upregulated in our dataset contributed to AMK and TOB
resistance of the double lysogen (Table 2.7). Tap, along with TetV (BB28_RS13560) target
tetracycline efflux, however, we did not consistently see an increase in TET resistance across all
our MIC trials (De Rossi et al., 2002; De Rossi et al., 1998). Although M. chelonae lacks an erm
gene, there was a slight elevation in the whiB7 regulon gene, hflx, but this did not result in a
significant change in CLA resistance (Rudra et al., 2020).
There are likely other mechanisms of intrinsic resistance at play that contribute to
increased aminoglycoside resistance in McProf-carrying strains. Although whiB7 expression was
highest in the double lysogen (BPs, McProf) treated with ACI among the four strains, whiB7
expression levels in the single McProf strain did not correlate with its relative AMK resistance
among the four strains. AMK is also a potent inducer of whiB7 expression in mycobacteria, but
surprisingly, AMK had little to no effect on whiB7 expression in strains carrying McProf (HurstHess et al., 2017). Conversely, whiB7 expression was significantly upregulated in strains lacking
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McProf. It is possible that McProf somehow alters cell wall permeability. A decrease in
permeability would likely contribute to the observed AMK resistance in these strains, and
further investigating this potential effect will be important to understanding the impact of
prophage on drug resistance.
We do not yet know how phage-encoded proteins from the two prophages, BPs and
McProf, interact to alter whiB7 expression in the double lysogen strain. The McProf genome
appears to only express genes through lysogenic infection of M. chelonae, whereas BPs can
carry out lysogenic and lytic infection (via induction) in a population of double lysogen cells. It’s
therefore possible that either lytic or lysogenic gene expression from BPs interacts with McProf
through an unknown mechanism to alter whiB7 expression. Alternately, the McProf-encoded
ESX-like polymorphic toxin cassette should be investigated for contributions to altering whiB7
expression. Activated toxin systems could potentially act as a trigger to the WhiB7 stress
response. Sub-inhibitory concentrations of antibiotics and BPs phage infection both enhanced
antibiotic resistance in M. chelonae in the presence of prophage McProf (Figures 2.1 and 2.3),
conditions also known to activate toxin systems (Kumar et al., 2019; LeRoux et al., 2015;
Slayden et al., 2018; Wang et al., 2011). Toxin/antitoxin (TA) systems are also known to function
as stress response modules and regulators of adaptive responses to stresses associated with
host environment and drug treatment (Slayden et al., 2018). TA systems also stabilize
replicative elements (e.g. plasmids and prophage) and defend against phage lytic infection (Yao
et al., 2018; Fraikin et al., 2020; Wozniak et al., 2009). The increased stability of the BPs
prophage in the presence of McProf compared to BPs lysogens in the cured M. chelonae
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(McProf) and its reported instability in M. smegmatis strains suggests that the polymorphic
toxin system encoded by McProf is active (Sampson et al., 2009; Broussard et al., 2013).
Our novel research findings indicate that prophage could be drivers of important
intrinsic antibiotic resistance genes in response to stresses. To determine the mechanism by
which phage alter intrinsic antibiotic resistance in mycobacteria, we are exploring the function
and impact of specific phage genes on expression of whiB7.
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CHAPTER 3
CHARACTERIZING THE ROLE OF PHAGE BPS GENE PRODUCTS IN INCREASED WHIB7
EXPRESSION IN STRAINS OF MYCOBACTERIUM CHELONAE CARRYING MCPROF

3.1 Chapter Summary
Mycobacterium abscessus is a nontuberculous pathogen associated with lung and
disseminated infection and is becoming a major public health concern (Griffith, 2019).
Emergence of extensively drug resistant strains has hindered effective treatment (Griffith,
2019). Common among these strains are integrated bacteriophage genomes (prophage) that
are hypothesized to contribute to mycobacterial fitness and virulence (Fan et al., 2015). How
prophage impact bacterial fitness, particularly when they don’t encode an obvious virulence
factor, is not understood.
We are investigating the role of prophage in mycobacterial fitness and antibiotic
resistance in M. chelonae, a member of the M. abscessus/M. chelonae complex which carries a
naturally occurring prophage, McProf. Previous RNAseq analysis of M. chelonae (McProf)
carrying a second prophage, BPs, showed drastic changes in bacterial gene expression relative
to the wildtype strain, as well as BPs single lysogen and non-lysogen strains. This included
significant upregulation of whiB7, a conserved mycobacterial transcriptional activator that
regulates genes associated with antibiotic resistance and stress adaptation (Morris et al. 2005;
Burian et al., 2012). To investigate the role of BPs on whiB7 expression in double lysogens (M.
chelonae (BPs, McProf)), we constructed recombinant strains of M. chelonae (McProf) to
express lysogenic BPs genes, gp5, gp33, and gp58. qRT-PCR analysis of these strains
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demonstrated no significant impact on whiB7 expression, indicating that BPs lysogenic gene
products alone do not contribute to increased whiB7 expression observed in M. chelonae (BPs,
McProf). Taken together, these data suggest that altered expression of whiB7 may be caused by
an alternative interaction between BPs and the naturally occurring prophage, McProf.
Identifying prophage-encoded factors that contribute to fitness will be important in developing
alternative treatment strategies for mycobacterial infections.
3.2 Introduction
Non-tuberculous mycobacterial infections are becoming increasingly prevalent and are
difficult to treat due to high levels of intrinsic antibiotic resistance (Nessar et al., 2012).
Emergence of extensively resistant strains presents a new challenge where infections are
essentially impossible to eradicate, especially in the case of Mycobacterium abscessus
(Johansen et al., 2020). While mutations in drug targets have explained extensive resistance in
some M. abscessus isolates, it does not account for all of these phenotypes (Guo et al., 2020).
All extensively resistant isolates, however, have elevated expression of the conserved
mycobacterial transcriptional activator, whiB7 (Griffith, 2019; Guo et al., 2020).
whiB7 regulates genes involved in intrinsic antibiotic resistance and stress adaptation
and is typically upregulated under stress conditions such as drug treatment and the intracellular
environment of macrophage (Morris et al., 2005; Burian et al., 2012). However, the cause of
this increased expression in extensively resistant strains in the absence of environmental
triggers remains unknown. Recently, we demonstrated that integrated viral genomes
(prophage) play a role in upregulation of whiB7 (Cushman et al., 2021).
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Most pathogenic bacteria carry prophage that are known to contribute to fitness and
antibiotic resistance. For example, the Pf4 prophage in Pseudomonas aeruginosa influences
biofilm formation which allows for drug tolerance (Rice et al., 2009; Wang et al., 2016).
Macrolide resistance is observed in multi-drug resistant strains of Streptococcus pyogenes that
is conferred by a prophage-encoded erythromycin resistance, or erm gene (Hyder and
Streitfeld, 1978; Wang et al., 2016). The majority of sequenced pathogenic mycobacteria to
date carry at least one prophage or prophage-like element (Bibb and Hatfull, 2002; Fan et al.,
2014; Dedrick et al., 2021). Recent efforts in sequencing clinical M. abscessus isolates showed
that 85% of strains carry at least one prophage (Dedrick et al., 2021). Dedrick et al. (2021)
identified 67 novel prophage sequences that have been assigned to 17 Mab clusters (A – Q)
based on >35% shared gene content. However, their role on fitness and virulence has not been
explored.
M. chelonae, an opportunistic pathogen belonging to the M. abscessus/M. chelonae
complex, serves as an ideal model for studying the impact of prophage and mechanisms of
antibiotic resistance in pathogenic mycobacteria. In addition to sharing >80% sequence identity
with M. abscessus, M. chelonae also encodes a whiB7 regulon that shares 103 of the 128 genes
identified in the M. abscessus regulon (Hurst-Hess et al., 2017). Additionally, it carries a novel
cluster MabR prophage (McProf) that is closely related to prophages identified in the genomes
of clinical M. abscessus strains (Molloy, Unpublished). Our previous work demonstrated that
the addition of a second prophage, BPs, to wildtype M. chelonae (BPs, McProf) to form a double
lysogen increased both whiB7 expression and resistance to aminoglycosides, amikacin and
tobramycin. This phenotype was not observed in strains lacking the McProf prophage (BPs
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single lysogen and non-lysogen strains of M. chelonae) suggesting an interaction between the
two prophages occurs to increase whiB7 expression (Cushman et al., 2021). How the two
prophages interact to alter gene expression is not understood. It appears that McProf is unable
to carry out a successful lytic infection in M. chelonae, and therefore only exists in its prophage
form. Conversely, there is evidence of both lytic and lysogenic BPs growth in cultures of double
lysogen cells. It is possible that either lytic or lysogenic BPs gene expression in the presence of
McProf is responsible for changes in gene expression. However, the BPs prophage is extremely
stable in the presence of the prophage McProf, and the majority of cells carry BPs in its
prophage form in a double lysogen culture.
Here we explore the role of the BPs lysogenic gene products on whiB7 expression in the
presence of prophage McProf. We have identified the lysogenic gene expression profile for BPs
in double lysogens of M. chelonae (BPs, McProf) and generated recombinant strains of M.
chelonae (McProf) to determine the impact of individual BPs lysogenic gene products on whiB7
expression.
3.3 Materials and Methods
3.3.1 Bacterial and viral strains
Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas, VA)
was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. The
wildtype strain of M. chelonae carries a naturally occurring prophage, McProf, and will be
referred to as M. chelonae (McProf). M. smegmatis MC2155 (ATCC®700084, American Type
Culture Collection) was cultivated in the same media in the absence of Tween 80 and grown at
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37˚C with shaking. Kanamycin (KAN) was used as a selective measure for recombinant strains at
a concentration of 250 μg mL-1 in liquid and solid media. Competent E. coli DH5 cells were
prepared by New England Biolabs, (Ipswich, MA) and grown in Luria broth base, Miller (BD)
supplemented with 50 μg mL-1 of KAN at 37˚C with shaking at 230 RPM for propagation of
plasmids. Bacterial strains used in this work are listed in Table 3.1. Plasmids used in this study
are listed in Table 3.2.
Mycobacteriophages BPs and CLED96 were obtained from the Hatfull Laboratory (Sampson
et al., 2009) and cultivated by plaque assay using M. chelonae (McProf) or M. smegmatis
MC2155. Serially diluted phage samples were incubated for 15 min at room temperature in 0.5ml aliquots of late log phase bacteria. Aliquots were plated in 4.5 ml of 0.45% 7H9 top agar
onto 7H10 agar plates. High titer phage lysate stocks were generated by flooding bacterial
lawns with nearly confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1
mM CaCl2, 68.5 mM NaCl). Viral strains used in this study are listed in Table 3.1.
Table 3.1 Bacterial and viral strains used in this study.
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Table 3.2 Plasmids used in this study.

3.3.2 Isolation of lysogenic strains
To generate BPs and CLED96 lysogen strains, M. chelonae (McProf) was serially diluted
and plated in 4.5 mL of 7H9 top agar onto 7H10-OAD agar plates. One set of plates was treated
with 109 plaque forming units (PFUs) of BPs or CLED96, while the second set was untreated.
Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in liquid culture to
test for phage particle release and superinfection immunity. Efficiency of lysogeny was
calculated by dividing the number of colonies on virus-treated plates by the number of colonies
on non-treated plates and multiplying by 100 to yield a percentage.
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Genomic DNA was extracted from the M. chelonae (BPs, McProf) double lysogen and
sent to Jackson Laboratory for sequencing (Genome Technologies at Jackson Laboratory, Bar
Harbor, ME). Whole genome libraries were prepared and sequenced on a 2x150-bp MiSeq run.
The presence of the BPs prophage was confirmed through reads that did not align to the
bacterial reference genome. Primers were designed to PCR amplify BPs attachment sites, attL
and attR, to confirm prophage integration for continued cultivation of lysogen strains (Table
3.3). This same PCR assay confirmed presence of the CLED96 prophage as well. The lysogen
strains carrying the BPs and McProf or CLED96 and McProf prophages are referred to as M.
chelonae (BPs, McProf) and M. chelonae (CLED96, McProf) respectively (Table 3.1).
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Table 3.3 Standard PCR primers used in this study.

3.3.3 BPs read mapping and gene expression profile
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3.3.3 Construction of recombinant strains
Mycobacterial expression vector, pMO21, provided by the Hatfull Laboratory, carries a
phage encoded ParABS system and kanamycin resistance gene, but lacks a promoter region.
The plasmid was modified to include a constitutive Hsp60 promoter and is referred to as
pMOHsp. pMO21 was digested with NotI per the manufacturer’s recommendations (NEB) to
linearize the vector. Linearized vector was purified on a DNA clean-up column (NEB). Digested
pMO21 underwent a Gibson Assembly (NEB) reaction with a 445-bp G-block (Integrated DNA
Technologies, Coralville, IA) carrying an hsp60 promoter region and flanking regions
complementary to the plasmid ends to generate a vector with a constitutive promoter.
Products were transformed into competent E. coli cells (NEB) and plated onto L agar
supplemented with 50 µg mL-1 kanamycin (KAN). pMOHsp was linearized with KpnI according
to the manufacturer’s recommendations (NEB). Expression vectors were constructed using 432bp and 499-bp G-blocks (IDT) that each included 30 bp of plasmid backbone sequence that flank
the KpnI insertion site at the 5’ and 3’ end of the G-blocks and an internal sequence that
corresponds to the BPs gp58 ORF (39,973 − 40,308 bp) or the entire MPME1 sequence (39,824
− 40,308 bp) (Table 3.3). The BPs gp58 ORF G-block was inserted into pMOHsp to generate an
overexpression vector, while the MPME1 sequence was inserted into pMO21 and expressed
from its native promoter. Similarly, gp5 was PCR amplified to include extensions that
correspond to 30 bp of flanking sequence to the pMOHsp KpnI insertion site. Fragments were
assembled into the vector via Gibson Assembly (NEB) and transformed into competent E. coli
DH5 according to the manufacturer’s recommendations. Successful recombinant plasmids
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harvested from transformants were confirmed by PCR (Table 3.3) and are referred to as
pMOgp5, pMOgp57-58, and pMOgp58.
Bacterial expression vector, pMH94 (Lee et al., 1991) is integration-dependent and
includes an L5 integration cassette and kanamycin resistance gene. The vector was digested
with SalI per the manufacturer’s recommendation (NEB) in order to linearize the vector and
remove the L5 integrase cassette. Fragments were separated on a FlashGel Recovery Cassette
according to the manufacturer’s instructions (Lonza, Rockland, ME) and a 4,136 bp fragment
was recovered. The BPs integrase (gp32), attP site, immunity repressor (gp33) and upstream
intergenic region including the native promoter (29,521 − 27,696 bp) were PCR amplified with
primers that include 30-bp 5’ extensions that correspond to the ends of SalI-digested pMH94.
Similarly, a control vector was constructed by PCR amplifying the BPs integrase, the attP site,
and the 3’ end of gp33 (29,270 − 27,696 bp) to prevent a functional immunity repressor from
being expressed. Each insert was cloned into SalI-digested pMH94 by Gibson cloning, as
described above, to generate pMHIR and pMHIattP (Table 3.2).
All vectors were electroporated into competent M. chelonae strains according to de
Moura et al. (2014). Briefly, electrocompetent M. chelonae cells were prepared by washing with
ice-cold 10% glycerol four times. Plasmid DNA in 500 ng quantities were electroporated with
100 µL of electrocompetent M. chelonae in 0.2-cm gap cuvettes. A sample of electrocompetent
cells lacking plasmid DNA served as a negative control. Electroporation was carried out in a
single pulse at 2.5 kV, 25 mF, 1,000 Ω. Cells were suspended in 900 µL of room-temperature
7H9-OAD and incubated at 30˚C with shaking for 4 h prior to plating on 7H10-OAD agar plates
supplemented with 250 µg mL-1 of KAN. Transformant colonies were PCR screened for presence
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of the plasmid (Table 3.3). Because our work involved analysis of gene expression, specifically
whiB7, plasmids were not maintained with antibiotic selection following generation of
recombinant strains. pMOHsp, pMO21, and their respective subclones were maintained by a
bacterial partitioning system encoded by the vector. pMH94 was maintained by integration into
the L5 attachment site and pMHIR and pMHIattP were maintained by integration into the BPs
attachment site. Successful expression of target genes in recombinant strains was confirmed by
qRT-PCR.
3.3.4 RNA isolations
Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at
an OD600 of 1.0. Samples were harvested into 6-mL of RNAProtect Bacteria Reagent (Qiagen,
Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. A first DNase
(Qiagen) treatment was performed on the columns. RNA was eluted in 50 L of hot nucleasefree water before undergoing a second DNase treatment using the Turbo DNA-Free Kit (Thermo
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the
RNA FlashGel System (Lonza, Rockland, ME) according to the manufacturer’s instructions.
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3.3.5 cDNA synthesis and qRT-PCR
cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting
samples 1:6 in 10 mM Tris.
Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100bp region with the gene of interest using Primer3 (Table 3.4). qRT-PCR assays were carried out
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted
1:6), and PerfeCTa SYBR Green Supermix (Quantabio) according to the manufacturer’s
instructions. Positive and no-template controls were included in each assay. Reactions were run
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT
method (Livak et al., 2001).
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Table 3.4 qRT-PCR primers used in this study.

3.4 Results
3.4.1 Organization of the BPs and CLED96 genomes and gene expression profile of BPs in the
M. chelonae double lysogen (BPs, McProf)
BPs is a temperate mycobacteriophage belonging to subcluster G1. Its genome spans
41,901 bp with a GC content of 66.6%, and it encodes 63 putative genes (Sampson et al., 2009).
BPs is closely related to G1 phage, CLED96, which is nearly identical in sequence to BPs (a fournucleotide difference) aside from lacking mycobacteriophage mobile element 1 (MPME1)
(Sampson et al., 2009). BPs has a broad host range and is able to infect multiple mycobacterial
species including M. smegmatis, M. tuberculosis, M. abscessus, and M. chelonae (Jacobs-Sera et
al., 2012).
Genome organization follows the typical synteny of bacteriophage in linear orientation
with structural and assembly components on the left arm followed by lysis and integration
cassettes, and replication and recombination components on the right arm (Sampson et al.,
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2009) (Figure 3.2). The lysis cassette includes gp27, gp28, and gp29, and encodes lysin A, lysin
B, and holin, respectively. The integration cassette is downstream of this region, separated by
two genes of unknown function. Gp32, gp33, and gp34 encode a tyrosine integrase, immunity
repressor, and Cro, respectively. Lysogeny maintenance and the stability of cluster G immunity
repressors is dependent upon phage genome integration into the bacterial genome (Broussard
et al., 2013). The phage attachment site (attP) is located on the 3’ end of the immunity
repressor (Broussard et al., 2013; Villanueva et al., 2015) (Figure 3.1). Therefore, integration of
the BPs genome into its host truncates the immunity repressor at the 3’ end (Villanueva et al.,
2015). This truncation results in translation of a functional repressor protein lacking the ssrAlike tag encoded on the C-terminus of gp33 that targets the protein for degradation (Villanueva
et al., 2015). The BPs prophage integrates into a tRNA-Arg (BB28_RS01100) in M. chelonae.
(McProf).
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Figure 3.1 Phamerator map of the BPs
integration cassette. The coordinates of the
BPs genome are represented by the ruler.
Genes are shown as colored boxes above
(transcribed rightwards) or below (transcribed
leftward) the ruler. RNAseq profiles are shown
for forward (blue) and reverse (red) DNA
strands. Note that the sequence reads are
mapped to the viral BPs genome rather than
prophage The map was generated using
Phamerator (Cresawn et al., 2011).

Both BPs and CLED96 are able to form stable lysogens in M. chelonae WT. The efficiency
of lysogeny was 25%, a significant increase compared to lysogens of M. smegmatis where
efficiency is closer to 5% (Broussard et al., 2013). In addition, particle release from BPs lysogens
of M. chelonae is low relative to BPs lysogens of M. smegmatis, measured at approximately 105
PFU mL-1 in M. chelonae lysogens compared to about 1010 PFU mL-1 in M. smegmatis lysogens.
RNAseq analysis of the BPs prophage in M. chelonae (McProf) showed that only two
genes are highly expressed. As expected, the immunity repressor (gp33) was highly expressed.
There was moderate expression from gp58, a gene of unknown function within a
mycobacteriophage mobile element 1 (MPME1) (Sampson et al., 2009). Left arm genes,
including gp5 and gp23 – 26 had low-level expression. Gp5 has no predicted function, although
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HHpred analysis resulted in strong hits to a ribosome modulation factor (Zimmerman et al.,
2018). Due to its location within an operon encoding structural genes, it is also likely functions
in particle assembly and structure. Gp23 – 26 also do not have predicted functions, but their
positioning between minor tail proteins and the lysis cassette suggests that they are also lytic
genes. It is likely that the low number of reads mapping to gp5 and gp23 – 26 are a result of
background lytic infection due to spontaneous induction in lysogen cultures.

76

77

Figure 3.2 Phamerator map of the BPs genome. The coordinates of the genome are indicated by the ruler (kb). Colored boxes
represent genes. Boxes above the ruler are rightward transcribed and those below the ruler are leftward transcribed. RNAseq
reads are mapped to the viral genome of BPs. The number of reads mapped are indicated on the y-axis. The lysogenic gene
expression profile, as determined by RNAseq is represented by blue (rightward transcribed genes) and red bars (leftward
transcribed genes). The map was generated using Phamerator (Cresawn et al., 2011).

3.4.2 BPs gp5 does not drive changes in whiB7 expression
Since we observed a significant increase in whiB7 expression in M. chelonae (BPs,
McProf) relative to the wildtype strain carrying McProf only, we decided to explore the impact
of BPs lysogenic genes expressed in the double lysogen on whiB7 expression in the presence of
prophage McProf, beginning with gp5.
BPs gp5 is located on the left arm of the phage genome within a region that encodes
structural genes that are typically only expressed during lytic growth. However, there is no
known function associated with this gene. Analysis of the protein coding sequence by blastP
indicated relation to a ribosome modulation factor identified in E. coli and T. thermophilus with
69% coverage. Ribosome modulation factors can promote translation of leaderless transcripts
(Beck and Moll, 2018). Leaderless transcripts are translated by pre-formed 70S ribosomes that
bind directly to AUG start codons, protecting the transcripts from degradation (Sawyer et al.,
2018; Beck and Moll, 2018). Nearly one quarter of mycobacterial transcriptomes are leaderless,
meaning ribosome binding does not occur at a ribosome binding site upstream of the transcript
start site (Canestrari et al., 2020). Since mycobacteria regularly translate leaderless mRNAs and
therefore carry pre-formed 70S ribosomes, it is possible that expression of gp5 aids in
stabilization of leaderless transcripts. This may alter mRNA levels of bacterial genes that could
leads to an increase in expression of whiB7 and its associated antibiotic resistance genes.
To investigate the role of gp5 on whiB7 expression, we constructed an overexpression
vector, pMOgp5, and isolated RNA from recombinant strains of M. chelonae carrying the
overexpression and control vectors. The gp5 ORF was cloned into pMO21 subclone vector
carrying a constitutive Hsp60 promoter (pMOHsp). This vector encodes a phage parABS system
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that allows for maintenance of the plasmid in the absence of antibiotic selection (Dedrick et al.,
2016). Recombinant and control strains were generated by introducing pMOgp5 and pMOHsp
respectively into M. chelonae (McProf).
To ensure that gp5 was being expressed from our recombinant strains, we used qRTPCR to measure levels of gp5 transcript in recombinant strains and compared this to gp5
expression levels in the double lysogen. M. chelonae carrying pMOgp5 expressed gp5 at a level
more than 20,000-fold higher than M. chelonae (BPs, McProf) (Figure 3.3a). Overexpression of
gp5 however did not affect whiB7 expression in the recombinant strain. M. chelonae
overexpressing BPs gp5 demonstrated no significant difference in whiB7 expression compared
to the empty vector control strain, and approximately 60-fold lower expression relative to M.
chelonae (BPs, McProf) (Figure 3.3b).
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Figure 3.3 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs gp5.
The average relative expression levels of BPs gp5 in M. chelonae (BPs, McProf) and M. chelonae
(McProf) (pMOgp5) (A) and whiB7 in M. chelonae (McProf) (pMOHsp), M. chelonae (McProf)
(pMOgp5), and M. chelonae (BPs, McProf) (B) as measured with SYBR Green qRT-PCR. Cultures
were grown to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs represent average
values ± standard error of the mean with n=3 and are representative of two independent trials.
Means with different letters are significantly different (Tukey’s HSD, α=0.05).

3.4.3 BPs gp33 does not drive changes in whiB7 expression
The immunity repressor, gp33, is the most highly expressed gene in the BPs prophage.
This is expected since phage repressors inhibit expression of genes associated with lytic
replication while in a lysogenic state (Dedrick et al., 2013; Petrova et al., 2015). Given that
repressors possess DNA binding capabilities, we wondered whether gp33 could modulate
bacterial gene expression as well, resulting in upregulation of whiB7. To investigate this, we
generated a recombinant strain of M. chelonae (McProf) (pMHIR) that encodes the BPs
immunity repressor (Table 3.2).
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We modified the integrative vector, pMH94, by removing the L5 integration cassette
and replacing it with the BPs integration cassette (Lee et al., 1991). Plasmid pMHIR encodes the
BPs integrase (gp32), the attP site, the entire immunity repressor (gp33) and the upstream
region including the native promoter. As a control, we constructed an additional vector,
pMHIattP, which encodes the integrase and attP site, but lacks the 5’ end of the immunity
repressor. pMHIR and pMHIattP were electroporated into M. chelonae (McProf). Vector
integration allowed for plasmid maintenance in the absence of antibiotics.
Expression of gp33 in recombinant M. chelonae (McProf) carrying pMHIR was confirmed
by qRT-PCR and did not differ from that of the double lysogen (BPs, McProf) (Figure 3.4a).
whiB7 expression was then assessed by qRT-PCR (Figure 3.4b). BPs gp33 did not significantly
alter whiB7, with near identical expression between the pMHIR strain and pMHIattP control
strain. Additionally, whiB7 expression was approximately 50 times greater in M. chelonae (BPs,
McProf), suggesting that the BPs repressor alone does not contribute to upregulation of whiB7
observed in the double lysogen strain.
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Figure 3.4 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs
gp33. The average relative expression levels of BPs gp33 in M. chelonae (BPs, McProf) and
M. chelonae (McProf) (pMHIR) (A) and whiB7 in M. chelonae (McProf), M. chelonae
(McProf) (pMHIattP), M. chelonae (McProf) (pMHIR), and M. chelonae (BPs, McProf) (B) as
measured with SYBR Green qRT-PCR. Cultures were grown to an OD600 of 1.0 before
harvesting RNA in triplicate. Graphs represent average values ± standard error of the mean
with n=3 and are representative of two independent trials. Means with different letters
are significantly different (Tukey’s HSD, α=0.05).

3.4.4 Co-expression of BPs gp5 and gp33 does not drive changes in whiB7 expression
Since BPs gp5 and gp33 did not impact whiB7 when expressed individually, we explored
whether co-expression of these genes have an effect on whiB7 expression. The gp33 transcript
appears to be leaderless, so we wondered if gp5 enhances production of repressor protein
(Broussard et al., 2013).
The pMOgp5 overexpression vector was transformed into the recombinant strain of M.
chelonae (McProf) expressing gp33 from pMHIR. RNA was isolated from M. chelonae (McProf)
(pMHIR, pMOgp5) and gp33 expression was compared to that of M. chelonae (BPs, McProf) and
M. chelonae (McProf) (pMHIR) by qRT-PCR (Figure 3.5a). Interestingly, gp33 expression was
slightly higher in the strain carrying both pMHIR and pMOgp5 relative to M. chelonae (BPs,
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McProf) and the strain carrying pMHIR alone. We then determined relative whiB7 expression in
these strains and found that expression was not significantly upregulated in the co-expression
strain compared to M. chelonae (BPs, McProf) (Figure 3.5b). whiB7 expression was
approximately 35-fold higher in the double lysogen. There was not a discernable difference in
whiB7 expression between M. chelonae (McProf) (pMHIR, pMOgp5) and M. chelonae (McProf)
(pMHIR). Overexpression of gp5 increased expression of gp33. However, this did not lead to
altered whiB7 expression, indicating that gp33 does not play a role in the regulation of whiB7.

Figure 3.5 qRT-PCR analysis of recombinant M. chelonae (McProf) strains co-expressing BPs
gp5 and gp33. The average relative expression levels of BPs gp33 in M. chelonae (McProf)
(pMHIR), M. chelonae (McProf) (pMHIR, pMOgp5), and M. chelonae (McProf, BPs) (A) and
whiB7 in M. chelonae (McProf) (pMHIR, pMOHsp), M. chelonae (McProf) (pMHIR, pMOgp5),
and M. chelonae (BPs, McProf) (B) as measured with SYBR Green qRT-PCR. Cultures were grown
to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs represent average values ±
standard error of the mean with n=3 and are representative of two independent trials. Means
with different letters are significantly different (Tukey’s HSD, α=0.05).
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3.4.5 BPs gp58 does not drive changes in whiB7 expression
While the role of BPs gp58, encoded by MPME1, is unknown, its significant expression
and potential to be a DNA binding protein made it worth investigating as a potential mediator
of bacterial gene expression. Similar to gp5, we developed a recombinant strain of M. chelonae
(McProf) expressing the gp58 ORF from the plasmid pMO21 to generate M. chelonae (McProf)
(pMOgp58). We also generated a strain carrying the plasmid, pMOgp57 – 58, which lacks the
Hsp60 promoter but encodes the entire MPME1 sequence to include its native promoter (Table
3.2). To determine if increased whiB7 expression occurs in double lysogens that lack gp58, we
created a lysogen of M. chelonae (McProf) using cluster G1 phage, CLED96, which is nearly
identical in sequence to BPs but lacks MPME1.
RNA was isolated from each strain and gp58 expression was confirmed by qRT-PCR
(Figure 3.6a). Expression of gp58 from pMOgp58 was over 2,000-fold higher relative to M.
chelonae (BPs, McProf) and expression of gp58 from pMOgp57 – 58 was comparable to the
double lysogen. Relative expression of whiB7 was then measured (Figure 3.6b). whiB7
expression did not significantly differ between the control strain M. chelonae (McProf)
(pMOHsp) and M. chelonae (McProf) strains expressing gp58 from the Hsp60 promoter
(pMOgp58) or from the MPME1 promoter (pMOgp57 – 58). Expression of whiB7 was
approximately 40-fold higher in M. chelonae (BPs, McProf) compared to gp58 expression
strains. Interestingly, M. chelonae (CLED96, McProf) demonstrated a 10-fold increase in whiB7
expression relative to the gp58 expression and control strains but was still significantly lower
compared to M. chelonae (BPs, McProf).
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Figure 3.6 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs
gp58. The average relative expression levels of BPs gp58 in M. chelonae (BPs, McProf) M.
chelonae (McProf) (pMOgp57 – 58), and M. chelonae (McProf) (pMOgp58) (A) and whiB7 in
M. chelonae (McProf) (pMOHsp), M. chelonae (McProf) (pMOgp57 – 58), M. chelonae
(McProf) (pMOgp58), M. chelonae (CLED96, McProf), and M. chelonae (BPs, McProf) (B) as
measured with SYBR Green qRT-PCR. Cultures were grown to an OD600 of 1.0 before harvesting
RNA in triplicate. Graphs represent average values ± standard error of the mean with n=3 and
are representative of two independent trials. Means with different letters are significantly
different (Tukey’s HSD, α=0.05).

3.5 Discussion
The prevalence of non-tuberculous mycobacterial disease has been steadily increasing
in recent years. Treatment of these diseases, specifically M. abscessus infections, is difficult to
manage due to extreme intrinsic drug resistance, posing a major health threat (Johansen et al.,
2020). Further, emergence of extensively antibiotic resistant isolates of M. abscessus has
rendered successful clearance of disease nearly impossible (Johansen et al., 2020). Extensive
resistance in some M. abscessus strains can be attributed to mutations in 16S or 23S rRNA, the
targets for aminoglycosides and macrolides respectively. However, mutations do not account
for extensive resistance observed in all clinical isolates (Guo et al., 2020). Common among
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extensively resistant M. abscessus strains is upregulation of transcriptional activator, whiB7,
which regulates many genes associated with antibiotic resistance and stress adaptation (Guo et
al., 2020; Morris et al., 2005; Burian et al., 2012). While whiB7 expression is known to be
induced by stress conditions such as sub-lethal drug exposure, phage infection, and the
intracellular environment of macrophages, the cause of upregulation in extensively resistant M.
abscessus remains unknown (Cushman et al., 2021; Burian et al., 2012). Better understanding
mechanisms of drug resistance in pathogenic mycobacteria is essential for developing more
effective treatments.
We recently reported on the novel observation that phage infection impacts whiB7
expression in mycobacteria. The presence of prophage BPs increases expression of whiB7 in M.
chelonae, but only in strains carrying the naturally occurring prophage, McProf. This suggests
that an interaction between BPs and McProf triggers an upregulation of whiB7 (Cushman et al.,
2021). McProf is only able to carry out lysogenic infection in M. chelonae. However, it appears
that BPs carries out both lytic infection and lysogenic infection in a population of M. chelonae
(BPs, McProf) cells (Cushman et al., 2021). It is unclear whether lytic or lysogenic BPs gene
expression alters whiB7 expression in the presence of McProf. Here we describe the role of BPs
lysogenic gene products on whiB7 expression in strains of M. chelonae carrying the McProf
prophage.
The function of gp5 is unknown, but HHpred analysis showed strong hits to a ribosome
modulation factor (Zimmerman et al., 2018). Ribosome modulation factors have the potential
to alter ribosome populations and subsequently alter gene expression at the translational level.
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Regardless of its true function, gp5 does not appear to contribute to increased whiB7
expression (Figure 3.3b).
The immunity repressor, gp33, is the most highly expressed gene from BPs and as a DNA
binding protein, was a likely candidate for altering bacterial gene expression. High expression of
the immunity repressor is expected given its role in preventing expression of lytic genes
(Petrova et al., 2015). We attempted to overexpress gp33 in M. chelonae (McProf) using a
pMOHsp backbone, which allows for maintenance of the plasmid through a ParABS system in
the absence of antibiotic selection (Dedrick et al., 2016). However, the gp33 recombinant
pMOHsp vector proved to be highly unstable and appeared to be lethal to bacterial cells. As an
alternative, we engineered the integrative plasmid, pMH94, to express the BPs repressor and
integration cassette from its native promote in place of the original L5 integration cassette. Our
analysis suggested that expression of gp33 alone in M. chelonae (McProf) does not significantly
change whiB7 expression (Figure 3.4b). Since gp33 is expressed as a leaderless transcript
(Broussard et al., 2013), we wondered if gp5 expression was necessary to facilitate translation
of gp33 by stabilizing the population of pre-formed 70S ribosomes. We co-expressed gp5 and
gp33 in M. chelonae (McProf) but found that whiB7 expression was not altered under these
conditions (Figure 3.5b). However, gp33 expression was nearly doubled in the co-expression
strain relative to M. chelonae (BPs, McProf) (Figure 3.5a). This suggests that when expressed at
a high level, gp5 may somehow enhance expression of gp33, potentially as a ribosome
modulation factor that aids in stabilization of leaderless transcripts by recruiting 70S ribosomes
to the 5’ end of transcripts to prevent degradation (Beck and Moll, 2018). This could explain
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increased gp33 transcript detected in M. chelonae (McProf) cells carrying both pMHIR and
pMOgp5.
While gp33 does not appear to impact whiB7 expression in M. chelonae, it is possible
that it has an alternate role in regulating bacterial gene expression. Gp33 functions as a
repressor by binding a 12-bp conserved palindromic sequence (5’- CGACATATGTCG - 3’)
upstream of lytic genes to block the binding of transcriptional machinery and prevent lytic gene
expression during lysogenic infection (Villanueva et al., 2015). We identified eight related
sequences within the regulatory region of the M. chelonae genome that could potentially serve
as gp33 binding sites. Of interest are three binding sites located upstream of a padR-like
transcription factor, which is the second most downregulated gene in M. chelonae (BPs,
McProf) (Cushman et al., 2021). The function of this transcription factor in M. chelonae is
unknown, but padR has been reported to regulate genes involved in stress responses, including
those involved in antibiotic resistance, often by serving as a repressor in other bacterial species
(Park et al., 2017; Vatlin et al., 2018). It is possible that gp33 inhibits padR expression and
subsequently results in de-repression of padR-mediated genes in M. chelonae to alter antibiotic
resistance. However, the relationship between gp33 and padR in altering genotype and
antibiotic resistance phenotype in M. chelonae would need to be investigated further.
BPs gp58 is moderately expressed and is encoded by mycobacteriophage mobile
element 1 (MPME1) (Sampson et al., 2009). We generated two plasmid constructs to
investigate the role of gp58 on whiB7: one overexpression vector and one vector carrying the
native promoter for gp58. Additionally, we analyzed whiB7 expression in M. chelonae (CLED96,
McProf). This essentially served as a gp58 deletion mutant since the genome of CLED96 is
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nearly identical to BPs aside from a four-nucleotide difference and its lack of MPME1.
Overexpression of gp58 did result in a statistically significant upregulation of whiB7 relative to
the control strain at a 2-fold increase but was still nearly 40-fold lower than that observed in M.
chelonae (BPs, McProf). Interestingly, the presence of the CLED96 prophage in M. chelonae
(McProf) increased whiB7 expression by about 10-fold but was still significantly lower than the
relative expression seen in M. chelonae (BPs, McProf) (Figure 3.6b). It is possible that
background lytic infection in double lysogens, regardless of whether the second prophage is
BPs or CLED96, could trigger an upregulation of whiB7 in the presence of McProf, but that
another interaction is necessary to see the ~40-fold increase in whiB7 expression observed in
M. chelonae (BPs, McProf). This suggests that while gp58 alone does not alter whiB7
expression, it may cooperatively interact with other factors to upregulate whiB7. This is evident
by the 30-fold drop in whiB7 expression when MPME1 is absent, but the rest of the prophage
remains intact, as seen in M. chelonae (CLED96, McProf) compared to the BPs double lysogen.
We do not know the function of gp58, but it is possible that it possesses recombinase activity
given that it is the only gene encoded on MPME1. If this is true, it is possible that gp58 has DNA
binding potential and could interact with other BPs genes to alter bacterial gene expression.
Given that whiB7 expression is known to fluctuate in a cell density-dependent manner, RNA
isolations and qRT-PCR analysis should be repeated to confirm the impact of the CLED96
prophage on whiB7 expression in M. chelonae (McProf).
This work has allowed us to conclude that while both prophages, BPs and McProf, must
be present to induce a drastic upregulation of whiB7, individual BPs genes do not interact with
McProf to cause this effect. This implies that McProf may play a more important role in the
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interaction between these two phages. Therefore, the impact of McProf viral gene products in
the presence of BPs needs to be investigated to better understand whiB7 induction and
increased antibiotic resistance in M. chelonae (BPs, McProf). In addition, the role of BPs lytic
infection on whiB7 expression in M. chelonae (McProf) cells should be explored.
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CHAPTER 4
DETERMINING THE ROLE OF THE MCPROF POLYMORPHIC TOXIN CASSETTE ON WHIB7
EXPRESSION AND ANTIBIOTIC RESISTANCE IN MYCOBACTERIUM CHELONAE
4.1 Chapter Summary
Mycobacterium abscessus is a nontuberculous pathogen associated with lung and
disseminated infections. It is of growing concern due to its steady increase in incidence over the
last decade (Griffith, 2019; Johansen et al., 2020) and the emergence of extensively drug
resistant strains that have hindered effective treatment (Griffith, 2019). The majority of
pathogenic mycobacteria carry integrated bacteriophage genomes (prophage) that are
hypothesized to contribute to mycobacterial fitness and virulence (Fan et al., 2015). How
prophage impact bacterial fitness, particularly when they don’t encode an obvious virulence
factor, is not understood.
M. chelonae is a member of the M. abscessus/M. chelonae complex which carries a
naturally occurring prophage, McProf, that we hypothesize plays a role in mycobacterial fitness
and antibiotic resistance of the host. M. chelonae carrying the prophage McProf were
significantly more resistant to aminoglycosides relative to strains that lacked McProf (Cushman
et al. 2021). Aminoglycoside resistance was further enhanced by the addition of a second
prophage, BPs. RNAseq analysis of this strain, M. chelonae (BPs, McProf), showed drastic
changes in bacterial gene expression relative to strains carrying only McProf, only BPs or no
prophage. In the double lysogen strain (BPs, McProf) there was significant upregulation of
whiB7, a conserved mycobacterial transcriptional activator that regulates genes associated with
antibiotic resistance and stress adaptation (Morris et al., 2005; Burian et al., 2012; Cushman et
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al., 2021). The role of BPs lysogenic gene products was evaluated and did not appear to alter
whiB7 expression. There are numerous genes expressed from the McProf genome in the double
lysogen but strong gene candidates for regulating bacterial genes involved in the stress
response is a McProf-encoded polymorphic toxin system. To investigate the role of the
polymorphic toxin system on whiB7 regulation and amikacin resistance, we constructed a
strains of M. chelonae (McProf) that encodes three genes from the McProf putative Esx
secreted polymorphic toxin (PT) system with and without the prophage BPs. qRT-PCR analysis
demonstrated a 10-fold upregulation of whiB7 expression in the recombinant strain carrying
BPs relative to control strains, indicating that the McProf PT cassette plays a role in whiB7
expression levels when BPs is present. However, whiB7 expression levels were more than four
times lower than that observed in the double lysogen (BPs, McProf). An increase in AMK
resistance was not observed in recombinant strains. Taken together, these data suggest high
whiB7 expression may require additional interactions between BPs and the naturally occurring
prophage, McProf. Identifying prophage-encoded factors that contribute to drug resistance will
be important in developing alternative treatment strategies for mycobacterial infections.
4.2 Introduction
Mycobacterial disease is the second leading cause of death by an infectious agent
behind COVID-19 (WHO, 2020). Increasing prevalence of multi-drug resistant (MDR) strains has
rendered previous treatment options ineffective. M. abscessus is a rapidly emerging
nontuberculous pathogen that is primarily responsible for pulmonary infections but can also
cause disseminated disease. It is a major contributor to mortality among cystic fibrosis patients
and other immunocompromised individuals (Griffith, 2019). Currently, the only effective
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treatment option consists of a combination therapy using amikacin and clarithromycin for as
long as 2 years with harsh side effects (Hurst-Hess et al., 2017). Many strains have become
extensively resistant, or resistant to all available drugs. In some cases, mutations in drug targets
have been identified that cause this extensive resistance. However, the cause in many
extensively resistant strains remains unknown, making treatment essentially impossible (Guo et
al., 2020).
M. abscessus carries a broad range of antibiotic resistance genes that encode drug efflux
pumps and proteins that modify either drug targets or the antibiotics themselves, resulting in
inactivation (Johansen et al., 2020). Transcriptional activator, whiB7, regulates many of these
genes associated with antibiotic resistance (Morris et al., 2005; Burian et al., 2012). Common
among all extensively resistant clinical isolates of M. abscessus is increased expression of whiB7
compared to wild-type strains which may explain increased drug resistance (Burian et al., 2013;
Hurst-Hess et al., 2017; Guo et al., 2020). whiB7 is known to be upregulated in the presence of
environmental stressors, including the intracellular environment of a macrophage and
subinhibitory drug exposure (Morris et al., 2005; Burian et al., 2012). Extensively resistant
isolates exhibit this same upregulation without exposure to drug treatment or macrophage.
What triggers this increased expression of whiB7 in the absence of cell stress is not understood
The majority of MDR strains identified to date also carry one or more integrated viral
genomes, or prophage. Cells carrying prophage are called lysogens. Nearly all pathogens carry
prophage that are known to contribute to fitness and virulence (Brussow et al., 2004; Wang et
al., 2016). In some models, the role and mechanism of prophage impact is clear. This is the case
with E. coli 0157:H7. This strain, responsible for enterohemorrhagic disease, is pathogenic due
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to a toxin encoded by the Stx prophage (Kaper et al., 2004). In other models, the role is of
prophage clear, but the mechanism is not understood. E. coli K12 carries 9 prophages. Research
showed that as the number of prophages decreased through a series of curing experiments, so
did resistance to antibiotics. The strain lacking all prophages was most susceptible to drugs
(Wang et al., 2010). This work shows that there is a link between prophage and increased
antibiotic resistance, however what this link is remains to be investigated. The majority of
mycobacterial pathogens also carry prophage, and they are hypothesized to play a role in
virulence yet remain largely uninvestigated (Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull,
2002). Identifying the role of prophage in mediating intrinsic antibiotic resistance will provide
insight for developing new and more effective therapies for mycobacterial disease.
M. chelonae is a very close relative of M. abscessus, sharing greater than 80% of proteincoding sequences. However, M. chelonae is a safer alternative to work with while still
demonstrating characteristics of pathogenic mycobacteria (Morris et al., 2005; van Ingen et al.,
2009; Jaen-Luchoro et al., 2016). This makes M. chelonae an effective model for studying the
conserved mycobacterial WhiB7 regulon. We have shown that when M. chelonae, which carries
a naturally occurring prophage, McProf, is infected with a second prophage, BPs, both whiB7
expression and antibiotic resistance is significantly increased (Cushman et al., 2021). We
characterized the BPs and McProf prophages and investigated the role of BPs lysogenic gene
products on whiB7 expression. We found that whiB7 expression was not significantly altered
when individual BPs lysogenic genes were expressed in the presence of McProf, indicating that
McProf must play a larger role in inducing this resistant phenotype.
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The McProf prophage expresses 16 genes, of which the majority have no known
function (Cushman et al., 2021). There is strong expression from a gene cassette located on the
rightmost arm of the genome characterized as an ESX-secreted polymorphic toxin (PT) system
that we predict is secreted by a mycobacterial type 7 secretion system (T7SS). Polymorphic
toxin (PT) systems include a large multidomain PT protein with an N-terminal domain that
allows export and/or delivery to other cells and a C-terminus toxin domain that targets cellular
processes (DNAses, RNAses, NADases, etc) (Ruhe et al., 2020). Downstream of the PT gene is an
immunity protein that neutralizes the toxin domain and prevents self-intoxication (Ruhe et al.,
2020). Polymorphic toxins are secreted or delivered directly to adjacent cells, potentially
providing a beneficial interaction in cells carrying the immunity protein such as sharing of
nutrients and induction of cell signaling pathways (Wood et al., 2020; Garcia et al., 2016; Zhang
et al., 2018). Alternatively, absence of an associated immunity protein results in cell death. The
PT system of McProf is similar to PT systems described by Dedrick et al. (2021) in M. abscessus
prophages and include a small ESAT6-like protein with a WXG-100 motif, a PT protein with a
WXG-100 motif in the N-terminus followed by an immunity protein. The WXG-100 domains may
allow formation of heterodimers between the ESAT6-like protein and the PT prior to export
(Dedrick, 2021). McProf gp98 appears to encode the ESAT6-like protein which we are calling a
WXG-100 family protein. Gp97 is a predicted Tde-like polymorphic toxin that was first
characterized in Agrobacterium tumefaciens and likely exhibits DNase activity (Ma et al., 2018).
Gp97 includes a WXG-100 motif, characteristic of T7SS substrates, and a potential T7SS
secretion signal (YxxxD/E) in the N and C terminus respectively (Daleke et al., 2012). Gp96
encodes a predicted Tdi-like immunity protein that is typically paired with Tde polymorphic
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toxins (Ma et al., 2014). RNAseq analysis showed that these genes were not differentially
expressed in M. chelonae (BPs, McProf) relative to wildtype (McProf only) (Cushman et al.,
2021).
Toxin systems are activated by danger signals such as phage infection and drug
exposure, similar to whiB7, and may play a role in stress adaptation (Kumar et al., 2019; Morris
et al., 2005; Burian et al., 2012; Cushman et al., 2021). It is therefore possible that an active
McProf-encoded PT system could trigger a WhiB7 stress response. Other stress adaptation
systems such as toxin/antitoxin (TA) systems encoded by prophage have been shown to
increase resistance and persistence in the presence of antibiotics. In E. coli, prophage-encoded
TA pair RalR/RalA increases resistance to broad-spectrum fosfomycin and the RelE toxin of
prophage Qin leads to persistence in the presence of ciprofloxacin, ampicillin and tobramycin
(Christensen et al., 2001; Guo et al., 2014; Neubauer et al., 2009). Additionally, prophageencoded TA systems have been shown to mediate biofilm formation, stabilize mobile elements
such as plasmids and prophages, and confer abortive infection (Wang et al., 2011; Yao et al.,
2018; Fraikin et al., 2020; Wozniak et al., 2009; Dedrick et al., 2017). Toxin systems are
abundant in pathogenic mycobacteria relative to nonpathogens and are highly expressed in
especially virulent strains of M. tuberculosis (Kumar et al., 2019; Slayden et al., 2018). Further,
diverse prophage-encoded PT systems have been identified in 25 M. abscessus prophages with
close relation to McProf, as well as an additional 50 across 14 other Mab clusters, although
their functions are largely unexplored (Molloy, Unpublished; Dedrick et al., 2021). The role of
PT systems in mycobacterial drug resistance has not yet been described.
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In this study we constructed recombinant strains of M. chelonae (∆McProf) with and
without the prophage BPs to express the McProf PT cassette (gp96 – 98). We investigated the
role of the PT cassette on BPs prophage stability and measured whiB7 expression and amikacin
resistance in recombinant and control strains in the presence and absence of the BPs prophage.
4.3 Materials and Methods
4.3.1 Bacterial and viral strains
Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas, VA)
was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. The
wildtype strain of M. chelonae carries a naturally occurring prophage, McProf, and will be
referred to as M. chelonae (McProf). M. smegmatis MC2155 (ATCC®700084, American Type
Culture Collection) was cultivated in the same media in the absence of Tween 80 and grown at
37˚C with shaking. Kanamycin (KAN) was used as a selective measure for recombinant strains,
at a concentration of 250 μg mL-1 in liquid and solid media. Competent E. coli DH5 cells were
prepared by New England Biolabs, (Ipswich, MA) and grown in Luria broth base, Miller (BD)
supplemented with 50 μg mL-1 of KAN at 37˚C with shaking at 230 RPM for propagation of
plasmids. Bacterial strains used in this work are listed in Table 4.1. Plasmids used in this study
are listed in Table 4.2.
Mycobacteriophage BPs was obtained from the Hatfull Laboratory (Sampson et al., 2009)
and cultivated by plaque assay using M. chelonae (McProf) or M. smegmatis MC2155. Serially
diluted phage samples were incubated for 15 min at room temperature in 0.5-ml aliquots of
late log phase bacteria. Aliquots were plated in 4.5 ml of 7H9 top agar (0.45% agar) onto 7H10
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agar plates. High titer phage lysate stocks were generated by flooding bacterial lawns with
nearly confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1 mM CaCl2,
68.5 mM NaCl). Viral strains used in this study are listed in Table 4.1.
Table 4.1 Bacterial and viral strains used in this study.

Table 4.2 Plasmids used in this study.

4.3.2 RNA isolation
Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at
an OD600 of 1.0. Samples were harvested into 6-mL of RNAProtect Bacteria Reagent (Qiagen,
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Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. DNase
(Qiagen) treatment was performed on the columns prior to elution in 50 L of hot nucleasefree water. A second DNase treatment was performed using the Turbo DNA-Free Kit (Thermo
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the
RNA FlashGel System (Lonza, Rockland, ME) according to the manufacturer’s instructions.
4.3.3 Construction of recombinant strains
Bacterial expression vector, pMH94 (Lee et al., 1991) is integration-dependent and
includes an L5 integration cassette and kanamycin resistance gene. The vector was linearized
with EcoRI per the manufacturer’s recommendations (NEB). The McProf polymorphic toxin
cassette (gp96 – 98), including its native promoter (63,600 − 68,223 bp) was PCR amplified with
primers that include 30-bp extensions that correspond to the ends of EcoRI-digested pMH94.
The 3,628-bp insert was ligated into the vector using the Gibson Assembly Cloning Kit (NEB) and
transformed into competent E. coli DH5 according to the manufacturer’s instructions. Plasmid
was propagated in E. coli and successful recombinant plasmid was confirmed by diagnostic PCR
and sequencing (Table 4.3). The resulting plasmid is referred to as pMHESX (Table 4.2).
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Recombinant plasmids were electroporated into competent M. chelonae (∆McProf)
according to de Moura et al. (2014). Briefly, electrocompetent M. chelonae cells were prepared
by washing with ice-cold 10% glycerol four times. Plasmid DNA in 500 ng quantities were
electroporated with 100 µL of electrocompetent M. chelonae in 0.2-cm gap cuvettes. A sample
of electrocompetent cells lacking plasmid DNA served as a negative control. Electroporation
was carried out in a single pulse at 2.5 kV, 25 mF, 1,000 Ω. Cells were suspended in 900 µL of
room-temperature 7H9-OAD and incubated at 30˚C with shaking for 4 h prior to plating on
7H10-OAD agar plates supplemented with 250 µg mL-1 of KAN. Transformants were PCR
screened for the presence of the plasmid (Table 4.3). Because our work involved analysis of
gene expression, specifically whiB7, plasmids were not maintained with antibiotic selection
following generation of recombinant strains. pMH94 was maintained by integration into the L5
attachment site. Successful expression of target genes in recombinant strains was confirmed by
qRT-PCR (Figure 4.6).
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Table 4.3 Standard PCR primers used in this study.

4.3.4 Isolation of lysogenic strains
To generate BPs lysogen strains, M. chelonae (∆McProf) recombinant strains were
serially diluted and plated in 4.5 mL of 7H9 top agar onto 7H10-OAD agar plates. One set of
plates was treated with 109 plaque forming units (PFUs) of BPs, while the second set was
untreated. Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in 7H9
broth to test for phage particle release and superinfection immunity. Efficiency of lysogeny was
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calculated by dividing the number of colonies on virus-treated plates by the number of colonies
on non-treated plates and multiplying by 100 to yield a percentage. Primers were designed to
PCR amplify BPs attachment sites, attL and attR, to confirm prophage integration for continued
cultivation of lysogen strains (Table 4.3).
4.3.5 Phage particle release test
Cultures of recombinant M. chelonae (BPs) were grown to an optical density of 1.0. A 1mL sample of each strain was harvested. Cells were pelleted by centrifuging at 16,000 x g for 1
min. Resulting supernatant was passed through a 2-m filter (VWR International, Radnor, PA)
to remove residual bacterial cells and serially diluted 10-fold. Lawns of M. smegmatis were
created by mixing 0.5-mL of late log phase bacteria with 4.5 mL of 7H9 top agar and plating
onto 7H10 solid agar. Supernatant dilutions were applied in 5-L volumes onto bacterial lawns
and incubated overnight at 37˚C.
4.3.6 cDNA synthesis and qRT-PCR
cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting
samples 1:6 in 10 mM Tris.
Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100bp region with the gene of interest using Primer3 (Table 4.4). qRT-PCR assays were carried out
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted
1:6), and PerfeCTa SYBR Green Supermix (Quantabio) according to the manufacturer’s
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instructions. Positive and no-template controls were included in each assay. Reactions were run
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT
method (Livak et al., 2001).

Table 4.4 qRT-PCR primers used in this study.

4.3.7 Minimum inhibitory concentration assays
Minimum inhibitory concentration (MIC) assays were performed according to Burian and
coworkers (Burian et al., 2012) and Ramon-Garcia and coworkers (Ramon-Garcia et al., 2013).
Cultures were grown in 7H9-OAD supplemented with 0.05% Tween80 at 30˚C with shaking and
sub-cultured such that overnight incubation resulted in an OD 600 of 0.1 - 0.3. Cultures were
diluted to an OD of 0.005 without Tween and incubated for a 1 h and applied in 50-L volumes
to wells of a 96-well plate containing 50-L 7H9 media with amikacin (AMK) concentrations that

103

varied by 2-fold dilutions (528 – 4 g mL-1). Each strain was applied in replicates of six at each
drug concentration and no-antibiotic controls were performed in replicates of 16. Additionally,
no-bacteria controls were included to serve as an absorbance blank. Inoculated plates were
sealed with porous adhesive culture plate films (VWR International), wrapped with parafilm and
incubated at 30°C for 2 d. A 5% solution of Tween80 and AlamarBlue (Bio-Rad) was added to
each well in 25- and 2-L volumes respectively, incubated at 30˚C for 1 d, and OD measured at
570- and 600 nm. Percent viability of cells was calculated as the percent difference in reduction
between antibiotic-treated cells and untreated cells according to the manufacturer’s
instructions. Each assay was replicated in three independent experiments.
4.4 Results
4.4.1 Generation of recombinant M. chelonae strains
Bacterial expression vector, pMH94, is integration-dependent and includes an L5
integration cassette and kanamycin resistance gene for plasmid maintenance (Lee et al., 1991).
Because our work involved analysis of gene expression and antibiotic resistance, it was
important to utilize a vector that would not require antibiotic selection. The region of the
McProf genome (coordinates 63,600 − 68,223 bp) that includes the polymorphic toxin cassette
(gp96 − 98) and its native promoter was PCR amplified and inserted into linearized pMH94 to
create pMHESX (Table 4.2). pMHESX and control vector, pMH94, were electroporated into M.
chelonae (∆McProf). BPs lysogens were created from strains M. chelonae (pMHESX) and M.
chelonae (pMH94) in order to determine if the McProf PT system stabilizes the BPs prophage
and how the PT cassette interacts with BPs to alter whiB7 expression and amikacin resistance.
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4.4.2 Expression of the McProf polymorphic toxin cassette stabilizes BPs single lysogens of M.
chelonae
Phage-encoded toxin systems are reported to aid in stabilization of replicative elements,
including plasmids and prophages (Yao et al., 2018). We wondered if the McProf PT cassette
stabilizes the BPs prophage given the increased efficiency of lysogeny and reduced particle
release observed in M. chelonae (BPs, McProf) relative to the BPs single lysogen (Cushman et
al., 2021). BPs lysogens of M. chelonae (pMHESX) and the control strain, M. chelonae (pMH94),
were grown to an optical density of 1.0 and phage particle release was measured in culture
supernatant (Figure 4.1). There was a difference of two orders of magnitude between the two
strains, with phage particles detected at concentrations of 2 x 107 PFU mL-1 and 2 x 105 for M.
chelonae (BPs) (pMH94) and M. chelonae (BPs) (pMHESX) respectively. Although we did not
determine if McProf PT system proteins are produced from the pMHESX plasmid, the
stabilization of the BPs prophage in the presence of pMHESX suggests that McProf PT system
gene products are being made in the recombinant strains.
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Figure 4.1 Phage particle release in recombinant M. chelonae (BPs). Supernatant of
recombinant M. chelonae (BPs) (pMH94) (A) and M. chelonae (BPs) (pMHESX) (B) were serially
diluted and applied to lawns of M. smegmatis.

4.4.3 The McProf polymorphic toxin cassette triggers upregulation of whiB7 in the presence
of phage BPs
To determine whether expression of the McProf-encoded PT cassette alters whiB7
expression in the presence of BPs, we measured relative whiB7 expression in recombinant
strains, and in M. chelonae (McProf) and M. chelonae (BPs, McProf) by qRT-PCR (Figure 4.2).
Expression of whiB7 was significantly elevated (approximately 10-fold) in M. chelonae (BPs)
(pMHESX) relative to M. chelonae (∆McProf) (pMH94). However, expression of whiB7 in M.
chelonae (BPs) (pMHESX) was not as high as whiB7 expression levels in the double lysogen
strain, which demonstrated a 45-fold increase relative to M. chelonae (∆McProf) (pMH94). As
expected, expression of the PT cassette in the absence of BPs (M. chelonae (∆McProf)
(pMHESX)) did not alter whiB7 expression. This suggests that while the McProf PT cassette
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elevates whiB7 expression in the presence of BPs, it is not the only factor causing the drastic
increase in whiB7 expression observed in M. chelonae (BPs, McProf).

Figure 4.2 qRT-PCR analysis of whiB7 in recombinant strains of M. chelonae expressing the
McProf polymorphic toxin cassette. The average relative expression levels of whiB7 was
measured in recombinant strains of M. chelonae (∆McProf) and M. chelonae (BPs) carrying
pMHESX or empty vector (pMH94) and compared to whiB7 expression in M. chelonae (McProf)
and M. chelonae (BPs, McProf) by SYBR Green by qRT-PCR. Cultures were grown to an OD600 of
1.0 before harvesting RNA in triplicate. Graphs represent average values ± standard error of
the mean with n=3 and are representative of two independent trials. Means with different
letters are significantly different (Tukey’s HSD, α=0.05).
4.4.4 The McProf polymorphic toxin cassette is downregulated in M. chelonae (BPs, McProf)
We confirmed that each of the PT cassette genes were expressed from pMHESX
recombinant M. chelonae strains by qRT-PCR and compared expression to that observed in M.
chelonae (McProf) and M. chelonae (BPs, McProf) (Figure 4.3). The expression profile of the
recombinant strains differed from that of the double lysogen (BPs, McProf). The WXG-100
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family protein and Tdi-like immunity protein were expressed at similar levels in both M.
chelonae (∆McProf) (pMHESX) and M. chelonae (∆McProf) (BPs) (pMHESX) relative to M.
chelonae (McProf) (Figure 4.3a and Figure 4.3c). However, expression of these genes in the
double lysogen was significantly lower. The expression levels of gp97, the Tde-like PT, was
higher in both recombinant strains, M. chelonae (∆McProf) (pMHESX) and M. chelonae (BPs)
(pMHESX) by approximately 6.5-fold and 5-fold relative to M. chelonae (McProf) whereas
expression levels in the double lysogen were the lowest (Figure 4.3b). This suggests that the
presence of an intact McProf prophage affects expression of gp97. Interestingly, all three genes
in the PT cassette were downregulated in M. chelonae (BPs, McProf). The presence of the BPs
prophage also appears to affect expression of genes in the PT system. The different expression
profiles between the single McProf and double lysogen (BPs, McProf) strains is in contrast from
the RNAseq data which did not detect significant differential expression of these genes.
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Figure 4.3 2-∆∆Ct qRT-PCR analysis of
polymorphic toxin cassette genes in
recombinant M. chelonae strains. The
average expression of the WXG-100-like
protein (A), the Tde-like polymorphic
toxin (B), and the Tdi-like immunity
protein (C) was measured in recombinant
strains of M. chelonae (∆McProf) and M.
chelonae (BPs) carrying pMHESX, as well
as in M. chelonae (McProf) and M.
chelonae (BPs, McProf), by SYBR Green
qRT-PCR. Cultures were grown to an
OD600 of 1.0 before harvesting RNA in
triplicate. Graphs represent average
values ± standard error of the mean with
n=3 and are representative of two
independent trials. Means with different
letters are significantly different (Tukey’s
HSD, α=0.05).
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To compare the ratio of PT to immunity protein, we plotted the average ∆Ct for each
gene by strain (Figure 4.5). The Tdi-like immunity protein is the most highly expressed gene in
the PT cassette in McProf-carrying strains, and PT expression is lower in McProf-carrying strains
compared to recombinant strains. In contrast, PT expression is higher in the recombinant
strains and immunity protein expression in nearly equivalent to that of the toxin, indicating that
the ratio of immunity protein to PT transcripts differ in the absence of an intact McProf

Forward

prophage (Figures 4.4 and 4.5). M. chelonae (BPs, McProf) has lower expression across the
entire cassette compared to other strains and the WXG-100 protein has the lowest expression
of the three PT cassette genes across all strains, as indicated by elevated ∆Ct values.

0 − 500
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92

Figure 4.4 McProf polymorphic toxin
cassette gene expression profile. The
coordinates of the McProf genome are
represented by the ruler. Genes are shown
as boxes above (transcribed rightwards) or
below (transcribed leftward) the ruler.
RNAseq profiles are shown reverse (red)
DNA strands. The number of reads mapped
are shown on the y-axis. The map was
generated using Phamerator (Cresawn et
al., 2011).
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Figure 4.5 ∆Ct qRT-PCR analysis of McProf polymorphic toxin cassette genes in
recombinant M. chelonae strains. The average expression of the WXG-100-like protein
(blue), the Tde-like polymorphic toxin (purple), and the Tdi-like immunity protein (green) was
measured in recombinant strains of M. chelonae (∆McProf) and M. chelonae (BPs) carrying
pMHESX, as well as in M. chelonae (McProf) and M. chelonae (BPs, McProf), by SYBR Green
qRT-PCR. Cultures were grown to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs
represent average values ± standard error of the mean with n=3 and are representative of
two independent trials. Significantly different means by gene across all strains are
represented by asterix (Tukey’s HSD, α=0.05).

4.4.5 Expression of the McProf polymorphic toxin cassette does not alter amikacin resistance
Previous work demonstrated that the presence of both BPs and McProf prophages
significantly increased the resistance of M. chelonae to aminoglycoside, amikacin, relative to
strains carrying one or no prophage (Cushman et al., 2021). We investigated whether
expression of the McProf PT genes in the recombinant strains in the presence and absence of
BPs increased AMK resistance through MIC assays (Figure 4.6). The AMK MIC was measured in
recombinant M. chelonae (∆McProf) and M. chelonae (BPs) expressing the PT cassette
(pMHESX) compared to respective strains carrying empty vector (pMH94). There was no
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significant difference in AMK resistance between the PT recombinant strains relative to control
strains carrying empty vector. The presence of the BPs prophage also did not affect AMK
resistance. The MIC for all four recombinant strains with and without the BPs prophage was 16
g mL-1. All strains showed enhanced resistance upon ACI treatment at an MIC of 32 g mL-1.
However, ACI treatment did not have a greater effect on M. chelonae (BPs) (pMHESX)
compared to M. chelonae (∆McProf) (pMHESX), nor did strains carrying the control vector
demonstrate lower resistance upon ACI treatment relative to pMHESX-carrying strains.
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Figure 4.6 Percent viability of recombinant M. chelonae strains upon AMK treatment in the
presence and absence of ACI. Percent viability of M. chelonae (∆McProf) (McMP), and M.
chelonae (BPs) (Mc (BPs) carrying pMHESX (ESX) or empty vector (94)) in the presence of
varying concentrations of amikacin. To determine if the presence of the McProf PT cassette
interacts with sub-inhibitory concentrations of antibiotics, each strain was treated or not
treated with 75 μM acivicin (ACI). Graphs represent average values  SE of the mean with n=3.
The optical density of was measured at 570- and 600 nm after the addition of 2 μL of
AlamarBlue and the percent difference in reduction between antibiotic-treated cells and
untreated cells was calculated. Data is representative of two independent experiments.
4.4 Discussion
The incidence of non-tuberculous mycobacterial disease has been on the rise and poses a
major public health threat. Effective treatment of these diseases, especially M. abscessus
infections, has proven to be difficult as a result of high levels of intrinsic drug resistance
(Johansen et al., 2020). Further, emergence of extensively antibiotic resistant isolates of M.
abscessus has rendered successful clearance of infections nearly impossible (Johansen et al.,
2020). Extensive resistance in some M. abscessus strains can be attributed to mutations in 16S
or 23S rRNA, the targets for aminoglycosides and macrolides respectively. However, mutations
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do not account for extensive resistance observed in all clinical isolates (Guo et al., 2020).
Common among extensively resistant M. abscessus strains is upregulation of transcriptional
activator, whiB7, which positively regulates many genes associated with antibiotic resistance
and stress adaptation (Guo et al., 2020). While whiB7 expression is known to be induced by
stress conditions such as sub-lethal drug exposure, phage infection, and the intracellular
environment of macrophages, the cause of upregulation in extensively resistant M. abscessus is
not completely understood (Cushman et al., 2021 and Burian et al., 2012). Better understanding
mechanisms of intrinsic drug resistance in pathogenic mycobacteria is essential for developing
more effective treatments.
We recently demonstrated for the first time that phage infection impacts whiB7
expression in mycobacteria. The presence of prophage BPs increases expression of whiB7 in M.
chelonae, but only in strains carrying the naturally occurring prophage, McProf. This suggests
that an interaction between BPs and McProf triggers an upregulation of whiB7 (Cushman et al.,
2021). Expression of individual BPs lysogenic gene products did not significantly alter whiB7
expression, suggesting that lytic infection by BPs and/or McProf gene products play a more
important role in altering whiB7 expression and antibiotic resistance (Molloy, Unpublished).
Here we explore the role of the McProf-encoded polymorphic toxin (PT) cassette on prophage
stability, whiB7 expression and amikacin resistance. We show that expression of the PT cassette
alone in the presence of the BPs prophage does significantly increase whiB7 expression but not
to the same degree of high expression levels observed in M. chelonae (BPs, McProf).
The genes in the McProf PT system play a role in stabilizing the BPs prophage in
mycobacteria. BPs forms comparatively unstable lysogens in mycobacterial strains that lack the
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McProf prophage with culture supernatant titers approaching 1010 PFU mL-1. In contrast,
culture supernatant titers of BPs lysogens of M. chelonae (McProf) or the PT recombinant strain
are 2 – 4 orders of magnitude lower (Figure 4.1) (Cushman et al., 2021). Active polymorphic
toxin systems are known to aid in the stabilization of replication elements, including prophage
and plasmids (Yao et al., 2018; Fraikin et al., 2020; Wozniak et al., 2009). We did not measure
protein production from gp96 – 98 in the recombinant strains. However, the drastic difference
in BPs titer in culture supernatants in the recombinant strains relative to controls suggests that
active gene products are likely being made at a high enough level to stabilize the BPs prophage,
possibly by killing cells in which BPs induction occurs.
The McProf PT system contributes to the whiB7 response, but not to the same degree as
strains carrying an intact McProf prophage. Toxin/antitoxin and polymorphic toxin systems are
activated by stressors such as phage infection and antibiotic exposure, and are abundant in
pathogenic mycobacteria (Kumar et al., 2019; Slayden et al., 2018; Wang et al., 2011). These
systems may also contribute to stress adaptation responses (Slayden et al., 2018). Our analysis
suggested that while expression of the PT cassette in M. chelonae (BPs) (pMHESX) does
increase whiB7 expression by approximately 10-fold, this system alone does not explain the
>40-fold increase observed in the double lysogen (BPs, McProf) (Figure 4.2). This likely explains
why there is not a difference in AMK resistance observed in pMHESX strains (Figure 4.5),
although MIC data is preliminary and should be repeated. It is possible that an additional
McProf-encoded factor(s), independently or through interactions with the PT cassette, are
necessary for high whiB7 expression in the presence of BPs. Therefore, the role of the other 13
genes expressed from the McProf prophage should be investigated.
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The PT cassette was actively expressed in recombinant strains; however, the expression
profiles contrasted those observed from RNAseq. While it remains true that the immunity
protein is the most highly expressed gene in the cassette, we found that expression of all three
PT cassette genes is significantly lower in M. chelonae (BPs, McProf) compared to both wildtype
M. chelonae and the recombinant strains (Figure 4.3). It is possible that differential expression
was not detected in RNAseq analysis as a result of low read coverage. While the McProf PT
cassette appears to be transcribed on the same operon, the stark difference in reads mapped
to the WXG-100 protein and the N-terminus of the toxin compared to the immunity proteins
suggests that there may be a hidden promoter within the C-terminus of the PT ORF that would
explain the heightened expression of the immunity protein in McProf-carrying strains (Figure
4.4). Together, this suggests that the McProf PT cassette is downregulated in the double
lysogen (BPs, McProf) but not when BPs alone is present, indicating that another McProfencoded component plays a role in regulating the polymorphic toxin system.
The difference in whiB7 expression between the recombinant BPs lysogen and the
double lysogen may be due to differences in the gene expression profile of the PT cassette
between strains. The Tdi-like immunity protein (McProf gp96) is more highly expressed than its
associated Tde-like toxin (McProf gp97) in McProf-carrying strains, whereas in the recombinant
strains, expression of the immunity protein and PT were nearly equal (Figure 4.5). It makes
sense for the ratio of immunity protein to toxin to be high in order to protect cells from PT
activity and similar expression profiles have been observed in prophage-encoded PT systems
identified in clinical M. abscessus strains (Dedrick et al., 2021; Harms et al., 2018). If PT
enzymatic activity is important for whiB7 expression, then a lower ratio of immunity protein to
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PT would likely affect residual toxin activity and potentially whiB7 expression. However, though
the PT cassette expression profiles between the recombinant strains are highly similar, this
would not explain the 10-fold difference in whiB7 expression in the presence and absence of
BPs. This suggests that the presence of the BPs phage likely affects regulation of the toxin
system at the post-transcriptional level. Because an intact McProf prophage is also important
for high whiB7 expression, it too may be important to PT protein activity and potentially results
in increased whiB7 expression. In Enterococcus, T7SS PT systems are known to be upregulated
by phage infection (Chaterjee et al., 2021). The presence of an intact McProf genome may
result in phage gene expression that activates the PT system in a way that affects whiB7
expression which cannot be observed in our recombinant strains.
We have shown that the McProf PT system does contribute to the whiB7 response in
the presence of the BPs prophage; however, the PT cassette alone does not explain the 45-fold
increase in whiB7 expression observed in M. chelonae (BPs, McProf). The impact of the other
genes expressed from the McProf prophage should be investigated in the presence of both the
PT cassette and BPs to explore whether a combination of McProf-encoded gene products is
responsible for inducing whiB7 expression upon infection by BPs.
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CHAPTER 5
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Pathogenic mycobacteria pose a major public health threat and are the second leading
cause of death by an infectious agent behind COVID-19 (WHO, 2020). Nontuberculous
mycobacterial pathogens are gaining prevalence, surpassing the incidence of tuberculosis in
most developed countries (Johansen et al., 2020). Mycobacterium abscessus is the most
intrinsically antibiotic-resistant species known. It is the causative agent of lung infections that
disproportionately affect immunocompromised individuals, such as cystic fibrosis patients.
These characteristics make M. abscessus infections difficult to treat, with a success rate of only
45% (Griffith, 2019; Johansen et al., 2020). Further, emergence of extensively antibiotic
resistant isolates of M. abscessus has rendered successful clearance of disease nearly
impossible (Johansen et al., 2020). While some extensively resistant isolates are caused by
mutations in drug targets, others appear to be a result of increased intrinsic drug resistance
with no known cause (Guo et al., 2020). Common among extensively resistant M. abscessus
strains is upregulation of conserved mycobacterial transcriptional activator, whiB7, which
regulates many genes associated with antibiotic resistance and stress adaptation (Guo et al.,
2020; Morris et al., 2005; Burian et al., 2012). The majority of extensively resistant clinical M.
abscessus strains identified thus far carry one or more prophage (Dedrick et al., 2021; Molloy,
Unpublished). Prophage are known to contribute to fitness and virulence in many pathogens,
but their role in mycobacteria has not been established (Fan et al., 2014). Characterizing the
pathways that lead to increased whiB7 expression and intrinsic drug resistance in pathogenic
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mycobacteria will be important for identifying new targets for novel drug development (Nessar
et al., 2012; Dheda et al., 2018).
This thesis has contributed to understanding the role of prophage on whiB7 expression
and intrinsic drug resistance in pathogenic mycobacteria. The McProf prophage is found
naturally in the pathogen M. chelonae where it plays a major role in regulating intrinsic drug
resistance via upregulating whiB7. My work suggests it does through the polymorphic toxin
system encoded within McProf. McProf belongs to a novel cluster, MabR (Molloy,
Unpublished). At least 25 clinical isolates of M. abscessus have been identified carrying McProflike or MabR prophage sequences (Molloy, Unpublished). Therefore, this work is significant to
the study of drug resistance in M. abscessus because the polymorphic toxin system encoded by
McProf is also common in strains of M. abscessus whiB7 pathway that is conserved in all
mycobacteria.
We expanded our understanding of this regulatory system by showing that the addition
of a second prophage, BPs, to M. chelonae (McProf) triggers a >40-fold increase in whiB7
expression and results in enhanced aminoglycoside resistance. In fact, whole genome RNAseq
analysis showed differential expression of 8.5% of M. chelonae genes in the presence of BPs.
We developed a four-strain model including single, double, and non-lysogens of M. chelonae
and found that both prophages must be present to observe a drastic increase in whiB7
expression and antibiotic resistance. Sub-lethal levels of Acivicin (ACI), are known to induce
increased expression of whiB7. We showed that it not only significantly increased amikacin
(AMK) resistance in all four strains but had the most pronounced effect on strains carrying
McProf. Not surprisingly, ACI treatment also significantly increased whiB7 expression in each
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strain. This allowed us to conclude that an interaction between McProf and BPs induces whiB7
expression and that exposure to sub-lethal drugs further enhances this effect. Notably, this is
the first report of phage infection serving as a trigger for the WhiB7 response. However, we saw
that when exposed to sub-lethal AMK, whiB7 expression was only substantially increased in M.
chelonae strains lacking McProf. We noted that ACI is a smaller molecule compared to AMK and
wondered if McProf somehow alters cell wall permeability. This could explain increased AMK
resistance in McProf-carrying strains, and why sub-lethal AMK doesn’t appear to significantly
impact whiB7 expression in M. chelonae (McProf) and M. chelonae (BPs, McProf). It would be
interesting to assess differences in cell wall permeability between all four M. chelonae strains
by measuring dye uptake using fluorescent microscopy. Ethidium bromide has been
successfully used to measure rate of uptake and efflux in mycobacteria, as it strongly fluoresces
when concentrated in the cytoplasm of Gram-positive bacteria (Rodrigues et al., 2011).
Therefore, these methods could be optimized to measure ethidium bromide uptake in M.
chelonae, and potentially uncover another layer of intrinsic resistance in mycobacterial
pathogens.
Given the dramatic increase in whiB7 expression and aminoglycoside resistance
observed in M. chelonae (BPs, McProf), but not in single or non-lysogens of M. chelonae, we
investigated the impact of BPs lysogenic gene products on whiB7 expression in the presence of
McProf. We identified three genes expressed by the BPs prophage and generated recombinant
strains of M. chelonae (McProf) to individually express these genes. qRT-PCR analysis
demonstrated that BPs lysogenic gene products do not significantly alter whiB7 expression. In a
population of lysogens, a random subset of cells spontaneously goes through induction, or a
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switch from lysogenic to lytic replication (Casjens, 2003). Therefore, the impact of BPs lytic
infection on whiB7 expression also needs to be investigated. This can be achieved by infecting
M. chelonae (McProf) with a BPs mutant that lacks the immunity repressor so that it is only
capable of lytic growth. We have generated such a strain using BRED technology (Marinelli et
al., 2008). RNA can be harvested throughout the infection cycle and temporal whiB7 expression
measured by qRT-PCR. Because the presence of McProf is necessary for whiB7 induction upon
BPs infection, as seen in M. chelonae (BPs, McProf), it is likely that BPs infection does not
directly alter whiB7 expression, but rather activates McProf gene products that results in stress
signaling that triggers a WhiB7 response. Therefore, the relative expression of McProf genes
should be monitored during lytic infection as well. Alternately, generation of a “super” double
lysogen by overexpressing the BPs immunity repressor in M. chelonae (BPs, McProf) would
serve two purposes. First, it could confirm that BPs lysogenic gene products truly do not
influence whiB7 expression. Second, overexpression of the immunity repressor would greatly
minimize or entirely prevent induction events. Overexpression of the BPs immunity repressor
was previously attempted using a constitutive Hsp60 promoter and appeared to be lethal to the
cell. To circumvent this, an inducible promoter could be used to control repressor expression
levels. If whiB7 expression is not upregulated in a super double lysogen, then it would be
plausible to further investigate BPs induction events as a contributor to whiB7 induction in the
presence of McProf.
Since BPs lysogenic gene products did not contribute to whiB7 upregulation, we looked
into the role of McProf gene products, specifically the polymorphic toxin (PT) cassette. While
expression of the McProf PT cassette did result in a 10-fold increase in whiB7 expression in M.
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chelonae (BPs), it did not fully account for the 45-fold increase observed in M. chelonae (BPs,
McProf). This suggests that other McProf-encoded factors may contribute to the induction of
whiB7 or affect the expression and/or activation of the McProf PT system such that higher
whib7 expression occurs and therefore should be investigated. McProf expresses 13 genes in
addition to the PT cassette. Each of these genes should be cloned into M. chelonae (BPs) and
the impact on whiB7 expression and aminoglycoside resistance evaluated. Of specific interest is
gp84. It does not have a predicted function; however, it is the most highly expressed McProf
gene. It is therefore possible that this gene product is somehow beneficial to McProf and/or its
bacterial host.
Another aspect to consider is a potential interaction between the McProf PT system and
an M. chelonae-encoded flotillin protein. The most highly upregulated gene in M. chelonae
(BPs, McProf) relative to the wildtype strain encodes a predicted flotillin protein with a 99-fold
increase in expression (Cushman et al., 2021). As it is not a member of the WhiB7 regulon, it
was not previously investigated, but orthologs have been identified in M. tuberculosis and M.
abscessus. The function of this gene in M. chelonae in unknown; however, in multidrug
resistant Staphylococcus aureus, it serves as a chaperone and contributes to virulence by
interacting with functional membrane microdomains and type 7 secretion system (T7SS)
components (Mielich-Suss et al., 2017). Further, phage infection in Enterococcus faecalis results
in increased expression of T7SS components and its substrates (Chaterjee et al., 2021). Taken
together, it is possible that the M. chelonae flotillin protein could be facilitating interactions
between T7SS substrates, such as the McProf-encoded polymorphic toxin, and the bacterial
membrane upon activation by BPs infection, potentially triggering a population-based WhiB7
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response. The impact of the McProf PT cassette on flotillin expression should be measured by
qRT-PCR to determine whether there is a link between the two systems. Additionally, a flotillin
knockout strain should be created from M. chelonae (BPs, McProf) to assess whether the
flotillin protein is involved in triggering an upregulation of whiB7.
In summary, this work has identified phage infection as a novel trigger of the WhiB7
stress response and increased drug resistance and has begun to uncover potential mechanisms
responsible for this response. Continuing to characterize these phage-host interactions is
important to better understanding the virulence of mycobacterial pathogens. Elucidating the
mechanisms of whiB7 upregulation and increased antibiotic resistance in pathogenic
mycobacteria will be essential to developing new therapeutic targets for multidrug resistant
infections.
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